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ABSTRACT 
In this thesis, we sought to determine if muscle-derived exercise-induced 
signaling via PGC-1α muscle activation influences neuroplasticity under 
physiological or pathophysiological conditions. For this purpose, transgenic 
mice with muscle-specific overexpression of PGC-1α that display an 
endurance exercise muscle phenotype were evaluated in models of cranial 
irradiation and photothrombotic stroke, as well as in aging and in a voluntary 
running paradigm. We also measured the response on proliferation and 
differentiation of NSPCs from treatment with either serum from exercised and 
transgenic mice, or conditioned media from PGC-1α-transfected myocytes. 
In paper I, we found that muscular PGC-1α overexpression in mice did not 
ameliorate irradiation-induced reduction of neurogenesis and rather resulted in 
increased infarct size without any differences in inflammatory response. In 
paper II and paper III, animals of both sexes displayed robust age-related 
reductions, and exercise-induced increases, in hippocampal neurogenesis. No 
differences were detected in these measurements between the genotypes. 
Further, transgenic animals had increased levels of myokines and reduced 
levels of pro-inflammatory cytokines. In paper IV, mouse sera from exercised 
or transgenic animals had no effect on proliferation of NSPCs, while 
conditioned medium from PGC-1α-overexpressing myocytes slightly 
increased proliferation. No differences existed in differentiation from 
treatment with different mouse sera or conditioned media. 
We conclude that artificial chronic muscle activation through the PGC-1α 
pathway, despite potent systemic changes, does not translate into exercise-
induced effects on hippocampal neurogenesis, and is not sufficient to mimic 
exercise-induced effects on recovery after cranial irradiation or stroke, or 
prevent age-related reduction in neurogenesis. Likewise, circulating factors in 
serum from exercised animals, or from animals with muscle-specific PGC-1α 
overexpression, are not sufficient to directly induce changes in proliferation or 
differentiation of NSPCs in vitro.  
Despite evidence indicating that exercise-induced factors from muscle and 
other tissues are capable of influencing brain function, our results highlight the 
difficulty in mimicking sustained effects of exercise on the brain. The study of 
PGC-1α and related molecular pathways, in muscle and other tissue, 
contributes to our understanding of mechanisms behind exercise-related 
benefits on the brain. 
POPULÄRVETENSKAPLIG 
SAMMANFATTNING 
Mekanismerna bakom konditionsträningens enastående effekter på hjärnan är 
fortfarande inte helt klarlagda. Inte minst gäller detta den avgörande rollen  av 
cirkulerande faktorer i blodet för träningsinducerad neurogenes, dvs. 
nybildningen av nervceller i hjärnan. Transkriptionsfaktorn PGC-1α anses vara 
en av de centrala faktorer som förmedlar träningens fördelar i 
skelettmuskulatur, inklusive frisättningen av faktorer i cirkulationen som kan 
påverka hjärnfunktion. I denna avhandling studerade vi hur ett specifikt 
överuttryck av PGC-1α i skelettmuskel bidrar till träningsinducerade effekter 
på hjärnan under fysiologiska och patofysiologiska förhållanden och om 
faktorer i blodet bidrar till dessa effekter. Vi använde en transgen musmodell 
med muskelspecifikt överuttryck av PGC-1α och fann att muskulärt PGC-1α 
överuttryck inte lindrade strålningsinducerad reduktion av neurogenes och 
istället resulterade i större infarkter utan påverkan på inflammatoriskt svar. 
Transgena och vildtyp djur av båda kön uppvisade en tydlig åldersrelaterad 
reduktion, och träningsinducerad ökning, av neurogenes i hippocampus. Ingen 
skillnad i dessa parametrar observerades dock för genotyp. Transgena möss 
hade ökade serumnivåer av myokiner och reducerade nivåer av pro-
inflammatoriska cytokiner. Vi fann även att musserum från tränade eller 
transgena djur inte hade någon effekt på proliferation hos neurala stam- och 
progenitor celler (NSPC) medan konditionerat medium från PGC-1α-
överuttryckande myocyter gav en lätt ökning i proliferation. Ingen skillnad 
fanns i differentiering mellan olika musserum eller konditionerade medier. 
Vi drar slutsatsen att artificiell kronisk muskelaktivering genom PGC-1α 
signalering, trots potenta systemiska effekter, inte översätts till 
träningsinducerade effekter på återhämtning efter kraniell strålning eller 
stroke, och inte heller skydd mot reducerad neurogenes vid åldrande. Vi drar 
även slutsatsen att cirkulerande faktorer i serum från tränade eller transgena 
möss inte är tillräckligt för att ge direkta effekter på proliferation eller 
differentiering av NSPC in vitro. Trots att studier visat att träningsinducerade 
faktorer från muskel och andra organ kan påverka hjärnfunktionen, 
understryker dock våra resultat svårigheten att efterlikna hållbara 
träningsinducerade effekter på hjärnan. Studier på PGC-1α och relaterade 
signaleringsvägar i muskel och andra vävnader bidrar till vår förståelse om 
mekanismerna bakom träningsrelaterade effekter på hjärnan. 
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INTRODUCTION 
Physical exercise, particularly aerobic exercise, has remarkable effects on the 
brain. It is considered a powerful treatment strategy to improve general brain 
health, brain plasticity, and cognition. The molecular mechanisms underlying 
these effects are still largely unknown, especially the essential role of systemic 
factors in the circulation. Recently, muscle been uncovered as a secretory organ, 
with many of the exercise-induced effects of endurance training in skeletal muscle 
orchestrated by the transcription factor PGC-1α (perixosome proliferator-
activated receptor gamma co-activator 1-alpha), including the release of 
downstream factors with neurotrophic properties. In this thesis, we sought to 
investigate if muscle-specific PGC-1α activation could contribute to exercise-
induced effects on the central nervous system. 
One of the most prominent and reproducible features of exercise in the rodent 
brain is increased hippocampal neurogenesis, i.e. the generation in new neurons 
in the adult hippocampus. The role of systemic factors in the circulation capable 
of influencing exercise-induced neurogenesis has just recently begun to be 
explored, with several circulating factors found to be essential for exercise-
induced neurogenesis (1). However, mechanisms underlying exercise-induced 
release of such signals are still unclear. Muscle releases factors with potent 
systemic effects during exercise, some which also influence the brain. With the 
identification of exercise-induced transcriptional regulators in skeletal muscle, 
such as PGC-1α, AMPK, and PPARδ, the possibility of genetic manipulations and 
pharmacological targeting has enabled ways to study the influence of muscle 
activation pathways on the body and brain. In 2012, activation of the exercise-
induced transcription factor PGC-1α in muscle was discovered to secrete systemic 
factors with health-promoting effects on other organs (2). With regards to the 
CNS, FNDC5, or irisin, was found to stimulate the expression of the important 
neurotrophic growth factor BNDF in the hippocampus, a brain region of central 
importance for learning and memory (3). Likewise, pharmacological activation of 
muscle activation pathways, such as AMPK and PPARδ, have yielded positive 
effects on hippocampal neurogenesis and spatial memory (4). Taken together, this 
implicates the involvement of muscle activation pathways in exercise-induced 
effects on the CNS. 
This thesis aimed at studying the effect of muscle-derived exercise-related signals 
on stem cell activation and brain plasticity as a means to improve recovery and 
protect from neurological conditions such as irradiation-injury to the brain, stroke, 
and age-related cognitive decline. In order to determine the effect of muscle-
derived factors, we overexpressed the transcription factor PGC-1α, considered to 
be responsible for many of the exercise-related benefits in muscle, including the 
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release of downstream factors into the circulation. This was done through the use 
of a transgenic mouse, in which the transcriptional co-activator PGC-1α is 
overexpressed under a muscle-specific promoter. This yields a chronic activation 
of skeletal muscle cells with an endurance exercise phenotype that can be used to 
study molecular mechanism underlying exercise-induced effects in skeletal 
muscle. The same gene was also overexpressed in a cell culture system of 
myoblasts to study how factors released from muscle cells into the medium 
influence neural stem cell behavior. These experiments give insights into how 
exercise-induced signaling influences neuroplasticity under physiological and 
pathophysiological conditions.  
Due to physical or mental constraints, whether induced by diseases or genetic 
makeup, many patients are unable to get the full benefits of exercise. By studies 
of cellular and molecular mechanisms, we are able to advance our knowledge 
about the interplay underlying the complex effects of exercise on the body. This 
knowledge would potentially aid the clinical implementation of exercise as a 
treatment option in health care. Identification of possible systemic signals that 
mediate some parts of exercise-induced effects could enable development of novel 
pharmacological strategies. Such signal molecules could be useful as therapeutics, 
either alone or as adjuvants to lifestyle changes, for treating disorders that 
otherwise would improve with exercise. A better understanding of molecular 
mechanisms could also enable identification of novel biomarkers for monitoring 
health status and optimization of physical therapy based on genetics and molecular 
responses. 
In this chapter, the effects and mechanisms behind exercise-induced effects on the 
body and brain are described, including the influence of exercise on adult 
neurogenesis. After this, the role of neurotrophic factors in the CNS and 
circulation are described, including the role of muscle and the PGC-1α pathway 
in exercise-induced signaling. Finally, we will provide a background on the 
experimental animal models employed in this thesis, including the transgenic 
mouse model, models of brain injury, and aging. 
Benefits of aerobic exercise 
Physical exercise undoubtedly has astonishing effects for the body and brain, and 
is a central life style factor for maintaining general health and wellbeing 
throughout life (5). Here, we focus on the effects of aerobic exercise, which is 
what primarily has been documented to improve health and function on the body 
and brain, while the health promoting effects of resistance exercise are less well 
established and outside the scope of this thesis. In this thesis, we use the terms 
‘physical activity’ and ‘physical exercise’ as defined by Caspersen, Powell, and 
Christenson (6), with ‘physical activity’ defined as “any bodily movement 
produced by skeletal muscles that results in energy expenditure” and ‘physical 
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exercise’ defined as “a subset of physical activity that is planned, structured, and 
repetitive, and has as a final, or an intermediate objective, the improvement or 
maintenance of physical fitness”. The minimum recommended levels of aerobic 
physical activity for maintaining health in adults determined by the World Health 
Organization (WHO) corresponds to 150 minutes per week of moderate-intensity 
activity, or alternatively, 75 minute per week of high-intensity activity. For 
children, WHO recommends at least 60 minutes of moderate-intensity physical 
activity daily. Moderate-intensity physical activity is defined as an activity level 
corresponding to at least 3 times the energy expenditure of rest (also known as 
metabolic equivalent; 1 MET), or an oxygen consumption rate (VO2) of over 45% 
of an individual’s VO2max (7).  
A very active life style, greatly surpassing the minimum recommendations of 
physical activity by the WHO, has been the norm throughout human evolution (8). 
From an evolutionary point of view, humans and other animals are built to run, 
due to the fact that movement has been a necessity for finding food and shelter, 
hunting, as well as escaping danger (9). In the animal kingdom, humans are poor 
sprinters compared to other species, but perform well at endurance running (10). 
Since humans evolved into running through simultaneous adaptations in 
metabolism, musculoskeletal system, and central nervous system, the human brain 
is likely dependent on exercise to function properly. Therefore, being active is an 
important factor of who we are as a species and health-promoting effects from 
endurance exercise should be regarded as the normal state, while physical 
inactivity should be regarded as the abnormal state. 
Technological advancements have led to a sedentary behavior in the global 
population, with physical inactivity being a major risk factor for chronic disease 
estimated as the fourth leading cause of death worldwide (11). One-third of adults 
worldwide, and half in the US (12), fail to meet WHO minimum 
recommendations, which can be translated into an enormous health economic 
impact for society. It should be noted that studies using accelerometers have 
demonstrated that self-reported data overestimates the levels of physical activity, 
suggesting that physical inactivity is an even more widespread problem than 
previously thought (13). Arem and colleagues pooled data from population-based 
prospective cohort studies in the US and Europe with self-reported physical 
activity levels for over 600,000 individuals, and from this data generated 
multivariable-adjusted hazard ratios over a mean follow-up period of 14 years 
(14). The study found that the WHO minimum recommended levels of physical 
activity corresponded to a ~30% lower risk of death, with maximum benefits for 
longevity, of ~40% lower risk, occurring at around 3 to 5-fold the recommended 
minimum. Physical inactivity is associated with increased risk for a range of 
chronic diseases, with low exercise capacity (VO2max) being an independent 
predictor of all-cause mortality and morbidity (15). VO2max is a measurement of 
exercise capacity, and corresponds to the highest energy demand that can be met 
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aerobically while exercising. It reflects many parameters simultaneously such as 
mitochondrial oxidative phosphorylation potential, cardiovascular and 
cardiopulmonary capacity, as well as neuromuscular function. Exercise intensity 
is relative to the individual and typically expressed as a percentage of an 
individual’s VO2max, in low- (<45%), moderate- (45-75%), and high-intensity 
(>75%). Interestingly, genes that govern physical activity levels, cardiorespiratory 
fitness, and risk of death have been found to be the same (16). 
Aerobic exercise offers many health benefits to the individual. It reduces all-cause 
mortality and has been reported to prevent and treat numerous chronic conditions, 
including metabolic, cardiovascular and pulmonary diseases, cancer, 
musculoskeletal and autoimmune disorders (17). Exercise leads to a long list of 
physiological improvements in the body including, but not limited to, 
improvements in musculoskeletal system, cardiorespiratory fitness, cardiac 
function, blood pressure, blood flow, vascularity, blood hemodynamics, glucose 
control, lipid profile, visceral adiposity, and immune function (18, 19). Exercise 
mediates a part of its effect by reducing systemic low grade inflammation which 
is associated to aging and many chronic diseases (20). 
Effects of exercise in the human brain 
In the brain, aerobic exercise reduces risk and represents a treatment strategy for 
neurodegenerative, cerebrovascular, and psychiatric illnesses, with physical 
inactivity being a risk factor for depression, dementia, and stroke (17, 21).  
In humans, physical exercise improves cognition with positive effects on learning, 
memory, attention, processing speed, and executive functions (22). Levels of 
physical activity and exercise capacity are also positively associated with 
academic achievement in children (23), intelligence in adolescents (24), as well 
as education and income (25). In addition, exercise improves several basic 
physiological functions governed by the CNS such as sleep (26), appetite (27), and 
mood (28). Structurally, exercise improves functional connectivity between 
different brain regions, thus improving the performance of important brain 
networks such as the central-executive and default-mode networks that recently 
have been discovered to be responsible for higher cognitive functioning (29). 
Exercise training also leads to increased hippocampal volume, and can prevent 
gray and white matter loss in prefrontal, parietal, and temporal cortex of older 
adults (30). Exercise may exert these behavioral and functional effects by 
correlated improvements in cerebral blood flow and brain oxygenation (18), anti-
inflammatory actions, or increases in release of growth factors (31). 
In rodents, one of the most reproducible effects of exercise on the brain is an 
increase in neurogenesis. Before detailing the mechanisms of exercise-induced 
neurogenesis and other exercise-related effects on the brain in rodents, we will 
shortly describe neurogenesis in the adult brain. 
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Adult neurogenesis 
In 1965, Joseph Altman serendipitously discovered that new neurons form in the 
adult rodent brain (32). However, this finding did not receive much attention until 
the 1980s when Nottebohm found that adult neurogenesis also occurs in 
songbirds, which later led to controversies regarding the existence of neurogenesis 
in mammals, and primates in particular (33). Since then, the field has come a long 
way and accumulating evidence supports the existence of adult neurogenesis in 
the human brain (34). The existence of human neurogenesis was first 
demonstrated by administering bromodeoxyuridine (BrdU) to terminal cancer 
patients for analysis of post-mortem brain tissue, proving that new neurons are 
generated in the human hippocampus even late in life (35). Human neurogenesis 
has also been confirmed to exist using an elegant method in the form of carbon-
14 dating, showing that neuronal turnover continuously occurs in the 
hippocampus of humans (36). The study reported that, one-third of the 
hippocampal neurons are subject to turnover, with 700 new neurons added in each 
hippocampus every day in adult humans, corresponding to an annual neuronal 
turnover of 1.75% with only a modest decline in turnover during aging. Since 
there is an obvious ethical and practical dilemma with trying to study neurogenesis 
in humans, rodent models have allowed us to better study this process. Even 
though studies in humans has correlated exercise to improved learning and 
memory, increased hippocampal volumes, and increased hippocampal blood flow 
(30, 37), it is still not known whether exercise-induced neurogenesis also occurs 
in humans.  
In mammals, neurogenesis takes place mainly during embryonic and early post-
natal developmental, but also to a lesser extent throughout adult life, i.e. adult 
neurogenesis. The two main neurogenic regions of the brain are the subgranular 
zone (SGZ) of the dentate gyrus (DG) in the hippocampal formation (35, 38) and 
the subventricular zone (SVZ) of the lateral ventricle walls (39).  
The hippocampal formation belongs to the limbic system located in the medial 
temporal lobe of the human brain. This region is considered to play a key role in 
learning, declarative, and spatial memory (40). The hippocampus formation is 
considered archicortex, which is a form of allocortex, i.e. non-neocortex. The 
archicortex, meaning ‘ancient cortex’, is the phylogenetically oldest region of the 
brain’s cortex, having three cortical layers instead of six layers as for the 
neocortex. The layers of the hippocampal formation are the dentate gyrus, the 
hippocampus proper, and the subiculum. Dentate gyrus consists of three different 
anatomical layers: the molecular layer (ML), the granular cell layer (GCL), and 
the hilus (polymorphic layer), see Figure 1. SGZ is a subregion of the GCL, 
outlining the border between the GCL and hilus. The middle layer of the 
hippocampus proper is called the pyramidal layer, or cornu ammonis (CA), and is 
divided into three regions (CA1-3). 
6  INTRODUCTION
Figure 1. Anatomical description of the different hippocampal subregions in 
mouse. The SGZ outlines the border between the GCL and hilus. The pyramidal 
layer (PL) is divided into three subareas (CA1-3). The stratum lucidum (SL) is a 
thin layer adjacent to the PL where the mossy fibers from the DG are located. GCL 
(blue), ML (magenta), hilus (green), PL (white), CA1 (yellow), CA2 (orange), and 
CA3 (red). 
Information flows through the hippocampus by three separate pathways, known 
as the trisynaptic circuitry (41), see Figure 2. The perforant pathway inputs 
information from other brain regions via the entorhinal cortex to the granular 
neurons of the GCL. The mossy fiber pathway consists of axonal projections from 
the granular neurons to the pyramidal neurons in the CA3. Finally, the Schaffer 
collateral pathway involves axonal projections from pyramidal neurons in the 
CA3 area to the CA1 area, for final output of processed information from the 
hippocampus to other brain regions. 
As for the other neurogenic region of the brain, the SVZ, newly generated 
neuronal progenitors migrate along the rostral migratory stream towards the 
rodent olfactory bulb where they integrate as interneurons (42), see Figure 3. For 
humans, however, SVZ neuroblasts migrate to the striatum, a region of importance 
for motor and reward systems (43).  
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Figure 2. Schematic illustration of the hippocampal trisynaptic circuitry. The 
circuitry consists of granular neurons in the GCL and pyramidal neurons in the 
CA3 and CA1 areas. 
Figure 3. The neurogenic niches of the rodent brain and the rostral migratory 
stream. The blue area reaching from the SVZ to the OB represents the RMS, 
along which neuroblast migrate to the olfactory bulb. RMS, rostral migratory 
stream. OB, olfactory bulb. 
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The process of adult hippocampal neurogenesis 
Adult hippocampal neurogenesis can be described to occur in four general phases: 
precursor phase, early survival phase, maturation phase, and late survival phase 
(44), see Figure 4. The process begins in the precursor cell phase with a highly 
proliferative bipotent radial glia-like (type-1) stem cell within the SGZ. These 
cells have astrocytic properties with a process attached to the basal membrane of 
blood vessels, thus having close interaction with endothelial cells and circulation. 
Type-1 cells undergo asymmetric division and generate transiently amplifying 
progenitor cells (type-2a/b) that rapidly divide and begin to migrate as they 
differentiate into neurons. Type-3 cells are migrating neuroblasts that have lost 
their proliferative capability. The early survival phase begins with neural 
progenitors exiting the cell cycle. The minority of early neuronal cells that survive 
begin to establish functional connections by extending their processes, axons into 
the hilus, and dendrites through the GCL into the ML. During the maturation 
phase, inhibitory GABAergic input from interneurons residing in the hilus 
promotes the maturation process until the excitatory glutamatergic input from the 
entorhinal cortex via the perforant pathway reaches the surviving maturing 
granular neurons. After cell cycle exit, a majority of newborn neurons undergo 
apoptosis within 10-12 days by default, however, survival of immature neurons 
can be increased by glutamatergic stimulation such as by cognitive stimuli in the 
form of new experiences and learning. In the late survival phase, the neuronal 
maturation process continues concomitant with increased synaptic activity and 
reduced threshold for long-term potentiation (LTP). Newborn neurons in the 
rodent brain becomes indistinguishable from mature neurons after approximately 
7-8 weeks.
Newly born neurons have a vital role in memory formation (45), with 
hippocampal neurogenesis being important for spatial memory (46) and pattern 
separation (47), i.e. the ability to discriminate between similar experiences. The 
dentate gyrus is also polarized in its functionality, with the dorsal hippocampus 
being associated with spatial learning and memory, and the ventral hippocampus 
being associated with emotional response (45). 
Neurogenesis has also been implicated in pathological conditions, as it is induced 
after ischemic stroke, traumatic brain injury and epileptic seizures (48-50). This 
pathological induction leads to neurons with ectopic integration, resulting in 
reduced memory function (51, 52). In Alzheimer’s disease, there is an initial 
increase in neurogenesis, theorized as the brains attempt to replace degenerating 
neurons (53), however, this initial increase is followed by a decrease at later stages 
of the disease (54). 
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Figure 4. Developmental stages and corresponding protein markers in 
hippocampal neurogenesis. The figure illustrates neural stem and progenitors 
migrating from the SGZ into the GCL as they differentiate and integrate into the 
hippocampal circuitry. 
Exercise-induced effects in the rodent brain 
In rodents, exercise leads to improvements in learning and memory, correlated 
with increased adult hippocampal neurogenesis, as well as neuronal and synaptic 
plasticity (55, 56). 
Exercise-induced adult hippocampal neurogenesis 
Exercise increases proliferation, survival, differentiation, and integration of newly 
born hippocampal neurons (55), resulting in increased volume of the GCL (56). 
The neurogenic response to running results in a ~2-3 fold increase in newborn 
neurons, depending on genetic background (57), age (58), labeling method used 
(59), and distance run (60). 
Running has a strong and acute effect on cell proliferation that occurs within 24 
hours from start of running, peaking at four to 10 days and levels out after four 
weeks (61, 62). This proliferative stimulus affects primarily type-2 progenitor 
cells in the hippocampus, likely by increasing survival of neuronal precursor cells 
rather than shortening their cell cycle (63). In addition to the hippocampus, 
exercise has also been found to increase adult neurogenesis in the SVZ (64) and 
hypothalamus (65), suggesting that the neurogenic effect of exercise may occur 
throughout the brain. Prolonged (66), but not short-term (67), voluntary wheel 
running may influence neurogenesis in the SVZ. Cell proliferation in non-
neurogenic regions are also regulated by exercise, but the patterns are complex 
and not yet fully understood (68). Apart from inducing proliferation, running also 
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increases survival and integration of newborn neurons (69). Even after 
proliferation returns to baseline, the population of immature doublecortin (DCX+)-
neurons continues to increase (62). Exercise-induced increase in number of 
DCX+-cells in the dentate gyrus has been correlated with running distance (70). 
Related to this is the fact that forced running on a treadmill does not seem to 
increase hippocampal neurogenesis as much as voluntary running, which leads to 
considerably longer running distances (57). However, rewarding mice for running 
increased running but did not further enhance neurogenesis, suggesting a ceiling 
effect (71). Also, neither high-intensity interval training or pure anaerobic 
resistance training have an effect on neurogenesis in rats (57). Even though 
increased neurogenesis is one of the most reproducible findings from exercise in 
laboratory animals, mice caught in the wild do not show an increase in adult 
neurogenesis after exposure to a running wheel (72), suggesting that an 
impoverished cage environment may cause a decrease in neurogenesis under 
standard rodent housing conditions which can be reversed by exercise. 
Exercise-induced neuronal and synaptic plasticity 
Exercise also induces potent changes in neuronal and synaptic plasticity. Running 
accelerates maturation of adult-born DG neurons, and induces changes in neuronal 
morphology and connectivity, such as increased dendritic length, complexity, and 
spine density of granular neurons (73). Running also increases afferent 
connections onto newborn neurons by recruiting presynaptic inputs from the 
entorhinal cortex, mammillary nuclei, and medial septum, regions important for 
relaying content and context of experiences, spatial-temporal information 
processing, and short-term memory (74). The increase in adult hippocampal 
neurogenesis is accompanied by an increase in LTP in the DG, a phenomenon 
driving the strengthening of synapses and considered as one of the major cellular 
mechanisms in learning and memory. Exercise lowers the LTP threshold level in 
the DG, as well as potentiates LTP-induced synaptic response (56). These changes 
in synaptic plasticity are likely mediated by newly born neurons that exhibit 
increased expression of glutamate receptors. At the same time, running increases 
expression of proteins involved in inhibitory neurotransmission in the form of 
GABA receptor subunits in hippocampus and pre-frontal cortex, with pre-synaptic 
GABAergic inhibition considered to be of importance in the maintenance of 
memory (75). 
Exercise-induced increase in blood flow and vascularization 
Aerobic exercise increases blood flow in the dentate gyrus both in humans and 
mice (37). The increase in blood flow likely increases both metabolic and trophic 
support to the neurogenic niche. Many factors that stimulate neurogenesis are also 
implicated in angiogenesis and maintenance of the vasculature, such as 
erythropoietin, Notch ligands, Sonic Hedgehog, fibroblast growth factor-2 (FGF-
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2), and vascular endothelial growth factor (VEGF). Exercise leads to an increase 
in blood flow with enhanced vascularity through vasorelaxation and angiogenesis 
in the hippocampus, striatum and motor cortex, known to be mediated by VEGF 
(76-78).  
Exercise-induce improvement in mitochondrial function and oxidative 
stress 
Mitochondrial function is a central aspect in survival and differentiation of neural 
progenitor cells (73), with neuronal mitochondrial density and oxidative capacity 
being positively influenced by exercise training. Oxidative stress results from 
incapacity to eliminate reactive molecules as a response to increased metabolism 
that attack and degrade proteins, nucleic acids and lipids. Even though there is a 
higher oxidative capacity in the mitochondria, exercise actually reduces oxidative 
stress and improves resistance to radical oxygen species (ROS) in mitochondria 
(79). This occurs through an increase in endogenous antioxidants, such as nitric 
oxide (77, 80), and detoxifying enzymes. 
Exercise-induced anti-inflammatory effects 
Inflammation can reduce electron-transport-chain enzyme activity, induce 
oxidative stress, and induce mitochondrial dysfunction, which in turn inhibits 
neurogenesis (81). Regular exercise has been reported to reduce low-level 
inflammation (82). While acute exercise appears to induce pro-inflammatory 
cytokines, exercise training is linked to an anti-inflammatory cytokine profile. 
Running intensity 
Studies have shown that wild mice spontaneously run in running-wheels that are 
placed out in nature (83), supporting the notion that the act of running occurs due 
to a reward-seeking behavior in rodents (84). Endocannabinoids have been 
involved in voluntary running behavior and regulates running performance (84).  
Rodents are nocturnal animals being most active during the night. Voluntary 
running in laboratory rodents occurs almost exclusively during the active, dark, 
phase of the animal, initially to increase in intensity for the first days until it peaks 
and stabilizes at a lower level (85). Voluntary running activity occurs in bursts in 
a periodical pattern likely influenced by the need for recovery (86). In mice, 
running distance varies across strains and gender from 3 to 12 km per day, and 
C57BL6 mice are in the top one-third segment of mouse strains (87).  
Since wheel-running triggers reward in rodents, they can keep on running for 
longer than what is good for them. Beneficial effects of exercise on the brain may 
be optimal at moderate intensity (88, 89), where more extreme levels of exercise 
are considered harmful. Excessive exercise leads to a high generation of ROS (90) 
with oxidative damage on DNA, RNA, proteins and lipids in the brain. This can 
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lead to disturbances in cellular, metabolic, and hormonal homeostasis, causing 
negative effects on learning and memory. Also, the compulsive behavior of 
running, despite being voluntary, might be experienced as stressful, with the 
release of adrenocorticotropic hormone (ACTH) and cortisol in relation to 
intensity and duration of exercise (91).  
Modulators of adult hippocampal neurogenesis 
Apart from exercise, hippocampal neurogenesis can be influenced by a many 
internal and external elements, such as environmental enrichment (92), stress (93), 
and blood-borne signals (45). 
An enriched environment is a multi-faceted challenge of senses and abilities. In 
rodents, this can be created by a spacious home cage, ability to socialize with other 
animals, adding toys and objects for the animals to climb on and investigate, and, 
importantly, giving them access to a running-wheel (92). The novel experiences 
appear to increase the activity-dependent survival of new adult-born hippocampal 
neurons (94). Enriched environment combines the proliferative effects of physical 
activity with the survival-promoting effect of a learning-based environment, 
leading to increased survival of newborn neurons than from with a running-wheel 
alone (95). 
The release of ACTH from the pituitary gland in response to stress, regulates the 
release of cortisol, an endogenous glucocorticoid, from the adrenal gland. Cortisol 
is important for learning and memory with glucocorticoid-receptors expressed 
throughout the brain including the hippocampus, prefrontal cortex, and amygdala 
(93). However, cortisol is a negative regulator of hippocampal neurogenesis, and 
reduces dendritic size and complexity of hippocampal neurons, as well as disrupts 
dendritic structure in the prefrontal cortex. Antidepressants, in contrast to stress, 
increase neurogenesis via cell proliferation, thereby associating increased 
neurogenesis with improvement in mood (96). 
The neurogenic niches in the SGZ and SVZ interact closely with the vasculature, 
to allow response to changes occurring in other parts of the body via the 
circulation (97, 98). Radial glial-like stem cells in the SGZ, and stem and 
progenitor cells in the SVZ, also have direct contact with endothelial cells, thus 
participating in the formation of the blood-brain barrier (99, 100). Signals from 
vasculature have been found to regulate cell proliferation and differentiation of 
neural stem and progenitor cells (NSPCs). Endothelial cells can respond to 
circulating factors in the blood stream, mediating communication via the 
circulation and NSPCs. Some blood-borne factors capable of influencing 
neurogenesis have also been found to cross the blood-brain-barrier to exert their 
effects directly in the neurogenic niche (45). Further, the beneficial effects of 
exercise, especially on endothelial cells, could be associated with blood flow-
induced shear stress, since vascular gene expression is influenced by the pattern 
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and magnitude of the shear stress (101), which enables endothelial cells to respond 
to mechanical signals from exercise-induced blood flow.  
Neurotrophic factors 
The plasticity-inducing effects of aerobic exercise on the CNS are mediated at 
least in part by neurotrophic growth factors, particularly brain-derived 
neurotrophic factor (BDNF) (31), but also circulating signals such as VEGF and 
insulin-like growth factor-1 (IGF-1). 
While many growth factors have effects on proliferation, differentiation, and 
survival in the CNS, neurotrophins are the ones most widely expressed in the CNS 
(102). BDNF is the best known neurotrophin and binds to (tropomysin receptor 
kinase B (TrkB) expressed in neurons, whereby the complex is internalized for 
activation of intracellular signaling pathways. BDNF has been found to be 
essential for hippocampal neurogenesis, neuronal and synaptic plasticity, as well 
as learning and memory. Further, BDNF also has been reported to induce 
angiogenesis in the hippocampus (103). BDNF is increased after a single bout of 
exercise in different brain areas including the hippocampus (31, 104). BDNF has 
been found to be essential for environmental enrichment-induced and 
antidepressant-induced increase in neuronal survival (105). 
BDNF, VEGF, and IGF-1 levels, are upregulated in the hippocampus from acute 
exercise, but return to basal levels within 2 days after ending chronic exercise, 
indicating that local upregulation only occurs from acute exercise bouts (88). 
Exercise-induced transcription of neurotrophic factors, such as BDNF and VEGF, 
has been shown to be greater in animals with lower exercise intensity than in those 
with higher intensity (106), supporting the idea that the dose-response relationship 
is not linear. Moderate and sustained aerobic exercise is therefore required for an 
adequate induction of neurotrophic growth factor response necessary for exercise-
induced hippocampal neurogenesis (57). 
Neurotrophic exercise factors 
Vasculature in direct vicinity can influence hippocampal neural stem cell 
proliferation and differentiation through signals from both endothelial cells and 
the circulation (97, 99), implicating that hippocampal NSPCs can readily respond 
to changes in oxygen, nutrients, hormones and other factors in the blood. Exercise 
factors, is a term describing circulating factors regulated by exercise. Skeletal 
muscle, liver and adipose tissue all release a variety of molecules and vesicles into 
the circulation upon exercise with potent systemic effects, of which some have 
neurotrophic influence on the CNS (1). 
BDNF, VEGF, and IGF-1, are essential for exercise-induced neurogenesis, all 
being upregulated in the circulation from exercise and capable of crossing the 
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blood-brain barrier (31, 107, 108). Additional factors have been reported to 
mediate effects on neurogenesis, such as cathepsin B (109), irisin (3), β-
hydroxybutyrate (110), beta-endorphin (111), adiponectin (112), and angiotensin 
II (113). 
Exercise-inducible myokines 
In 1961, Goldstein conducted cross-transfusion experiments between resting dogs 
and dogs in which muscle contraction was induced by electrical stimulation (114). 
He found that muscular work triggered humeral factors that could enhance glucose 
utilization in resting dogs. Decades later, interleukin-6 (IL-6) was discovered to 
be secreted from muscle stimulation, having potent effects on glucose and lipid 
metabolism (115). This designated skeletal muscle as an endocrine organ and IL-
6 as the first myokine.  
Myokines are factors released by muscle with autocrine, paracrine and/or 
endocrine effects (115). Myokines mediate signaling within the muscle and 
crosstalk with the liver, gut, pancreas, adipose tissue, bone, vascular bed and skin 
(1, 116), and are involved in the effects of exercise on metabolic and 
cardiovascular health.  
More than a decade ago, Bortoluzzi and colleagues identified ~300 myokines in 
human muscle (117), of which almost one quarter had not been previously 
characterized. Since then, many hundreds of other potential myokines have been 
identified, most of which are not uniquely released from muscle, but also from 
other organs such as adipose tissue (adipokines), liver (hepatokines) and immune 
cells. Exercise is known to elevate several myokines in the circulation, i.e. 
exercise factors, with endocrine effects, including IL-6, BDNF, VEGF, IGF-1, 
FNDC5/irisin, cathepsin B, FGF-21, musclin, decorin, GDF-15, IL-15, meteorin-
like, myonectin, SPARC, CCL2, ANGPTL4, and BAIBA (118). Exercise-
inducible myokines also have been reported to exert systemic effects on the CNS 
by improving spatial memory and stimulating BDNF expression in the 
hippocampus (3, 109, 119), see Figure 5. 
Myokines regulated by PGC-1α 
The mouse model overexpressing the transcription factor PGC-1α in skeletal 
muscle, mediates many of the cellular adaptations to endurance exercise in 
skeletal muscle. It led to the discovery of exercise-induced myokines with 
potential health-promoting effects (2). The PGC-1α pathway is known to regulate 
several exercise-induced myokines, including irisin, VEGF, cathepsin B, 
meteorin-like, BAIBA, 3-HIB, IL-15, and musclin (2, 118, 120), with some being 
reported to influence neuroplasticity, such as irisin, cathepsin B, and VEGF (1, 
31). 
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Figure 5. Neurotrophic exercise factors. Systemic factors are released from 
peripheral organs such as muscle, liver, and adipose tissue into the blood stream 
during exercise, which are capable of upregulating BDNF, VEGF, PGC-1α, and 
FNDC5, in the hippocampus, thereby resulting in increased neurogenesis, 
angiogenesis, neurotrophic factor expression, and learning and memory. 
FNDC5/irisin 
In 2002, a novel peroxisomal and membrane-bound protein named PeP was 
discovered, which later was renamed fibronectin type III domain-containing 
protein 5 (FNDC5). In 2012, Boström and colleagues discovered FNDC5 to be a 
PGC-1α-inducible protein that is cleaved and secreted into the circulation as the 
myokine irisin upon exercise (2). Irisin can induce browning of white adipocytes 
by increasing lipid metabolism, thermogenesis, and energy expenditure. From 
experiments in muscle and liver cell cultures, irisin also promotes intracellular 
uptake and storage of glucose and lipid, and in muscle cells promotes the shift 
from carbohydrate to fat metabolism (121). Irisin has also been reported to 
improve mitochondrial function in kidney tubule cells and being able to protect 
from kidney damage and fibrosis (122). 
Peripheral overexpression of FNDC5 protein in the liver by an adenoviral vector 
upregulated BDNF levels specifically in the hippocampus, but not in the forebrain 
(3). It is unclear if FNDC5 exert its effects directly by passing the blood-brain 
barrier (BBB), or indirectly through endothelial cells or other peripheral factors. 
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Further, intravenous administration of an FNDC5-containing adenoviral construct 
lead to overexpression of the protein in both brain and circulation, resulting in 
ameliorated memory impairment and improved synaptic plasticity in a model of 
Alzheimer’s disease (123). In the same mouse model, blockade of peripheral 
FNDC5 attenuated neuroprotective effects of exercise on memory and synaptic 
plasticity. Apart from being expressed in skeletal muscle and heart, FNDC5 has 
also been found to be highly expressed in the brain, including cerebellar Purkinje 
neurons and hypothalamus (124). FNDC5 has been found to be important for 
neuronal development and to be capable of inducing neuronal differentiation in 
embryonic neural stem cells (125). In a study by Wrann and colleagues, exercise 
upregulated Fndc5 mRNA in the hippocampus in a PGC-1α/ERRα-dependent 
manner (3). Overexpression of FNDC5 in cortical neuronal cultures increased 
BDNF gene expression, while knock-down of FNDC5 inhibited BDNF 
transcription. BDNF treatment of neuronal cultures led to downregulation of 
FNDC5 gene expression, indicative of a negative feedback mechanism. Even 
though FNDC5 is involved in neuronal differentiation, irisin did not induce 
neuronal differentiation in a murine neural stem cell line, but increased 
proliferation at 10 times the physiological concentration (126). Irisin protected 
against neuronal cell injury due to oxygen and glucose depravation (127), as well 
as improved morphological and functional outcome in a mouse model of middle 
cerebral artery occlusion (128). Further, blockade of irisin with an intravenously 
administered antibody attenuated the neuroprotective effects of physical exercise 
against cerebral ischemia. 
Whether exercise leads to increased levels of irisin in the bloodstream of humans 
has been controversial (129), which we will return to in the Discussion. Through 
the use of tandem mass spectrometry, circulating irisin was demonstrated to be 
upregulated with exercise training in humans at concentrations comparable to 
essential metabolic hormones, such as insulin and leptin (130). However, the 
functional relevance of irisin in humans remains to be determined. 
VEGF 
Neurogenesis and angiogenesis in the hippocampal neurogenic niche are closely 
co-regulated, with many of the factors that influence angiogenesis also influencing 
neurogenesis and maintenance of the vasculature. VEGF is one of the most 
important pro-angiogenic factors in most tissues and mediates its effect by binding 
to the tyrosine kinase receptor on endothelial cells (131). Intracerebral infusion of 
VEGF enhances angiogenesis, hippocampal neurogenesis, and cognition (131), 
with exercise alleviating anxiety and depression in a VEGF-dependent manner 
(132). 
Exercise induces VEGF expression specifically in the cortex, hippocampus, 
muscle and lung (133). VEGF is rapidly expressed in skeletal muscle cells after 
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an acute exercise bout (133, 134), where it has an essential role in 
neovascularization and endurance capacity. VEGF is also acutely and transiently 
upregulated in the circulation with exercise, but has a short half-life in blood (135) 
and does not appear to be upregulated in the circulation during the resting period 
in regular exercise training (88).  
Peripheral blockade of VEGF inhibits exercise-induced neurogenesis (107), but 
also neurogenic effects of enriched environment and anti-depressants (131, 136). 
Interestingly, selective ablation of VEGF in skeletal muscle is sufficient to inhibit 
exercise-induced effect on neurogenesis (137). It is still unclear if VEGF can cross 
the BBB, or if the effects on CNS are mediated through endothelial cells or 
indirect signaling to other peripheral organs. 
Cathepsin B 
Proteomic and biochemical analyses from treatment of L6 myotubes with the 
AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), led to 
the identification of cathepsin B in conditioned medium. This protein, capable of 
crossing the BBB, was upregulated in skeletal muscle and increased in muscle, 
hippocampus and plasma of mice, rhesus macaques and humans following 4 
months of treadmill training (109). Treatment of hippocampal NSPCs with 
recombinant cathepsin B increased levels of Bdnf mRNA, BDNF protein and 
levels of DCX (109), but did not affect cell proliferation. 
Kynurenic acid 
The essential amino acid tryptophan is metabolized to kynurenine, a substance 
which upon accumulation in the CNS can lead to neuroinflammation, depression 
and stress (138). Kynurenine aminotransferases convert kynurenine to kynurenic 
acid, which is not able to cross the blood–brain barrier (138). Exercise activates 
the PGC1α–PPARα–PPARδ pathway in skeletal muscle, which stimulates the 
expression of kynurenine aminotransferase, reducing plasma levels of kynurenine 
in rodents and humans (139). Transgenic mice with muscle-specific PGC1α 
overexpression are protected from neuroinflammation and depression induced by 
chronic stress (138). 
BDNF 
Even though BDNF is a crucial neurotrophic growth factor in the brain, the role 
of circulating BDNF in regulating exercise-induced plasticity is unclear. In human 
studies, BDNF is upregulated in a dose-dependent manner in the circulation 
correlated with improved spatial and verbal memory, enhanced pattern 
recognition, as well as alleviation of chronic stress and cognitive impairment (140, 
141). With between 70-80% of circulating BDNF considered to be released from 
the brain, changes in circulating BDNF following exercise may reflect altered 
BDNF expression in the CNS (104). A smaller portion of BDNF is also produced 
peripherally by skeletal muscle, endothelial cells, and immune cells, such as T-, 
B-cells and monocytes (141). In muscle, BDNF is being used at the neuromuscular
junctions, where it acts to induce protein synthesis and lipid metabolism. Even
though BDNF is an exercise-inducible myokine, it is unclear to what extent the
protein is released from muscle into the bloodstream during exercise (142). BNDF
can pass through the BBB by passive diffusion (141), with levels of BDNF in the
brain being directly influenced by levels in the blood, and vice versa. In blood,
90% of BDNF is stored in platelets and released during clotting, thus, serum
includes both freely and stored BDNF, with plasma only including the free
fraction.
Metabolites 
Lactate, a source of energy for CNS neurons, may have a role in exercise-induced 
changes in the brain, with blood-born lactate released from contracting muscles 
mediating VEGF-dependent vascularization in the CNS (143). Further, BAIBA is 
an example of a PGC-1α regulated metabolite released from muscle cells that 
induces adaptive thermogenesis in adipocytes, beta-oxidation in hepatocytes, and 
improves glucose homeostasis (144). However, its effects on the CNS are 
unknown. 
Inflammatory mediators 
Exercise induces muscle damage and release of inflammatory molecules after 
exercise. Immune cells control inflammatory reactions and support regeneration 
of muscle tissue following exercise. 
One example of an inflammatory mediator is IL-6, a cytokine with complex 
effects in the body, with effects varying depending on its mode of release. The 
cytokine was originally classified as a pro-inflammatory cytokine, and chronically 
elevated levels of IL-6 in the circulation was associated to inflammation and 
metabolic disease (116). However, IL-6 is also released from muscle upon 
exercise with acutely elevated levels in the circulation associated with anti-
inflammatory and beneficial metabolic effects. The cytokine also has a vital role 
in regulation of glucose homeostasis and lipid metabolism through effects on 
skeletal muscle, liver, adipose tissue, and pancreatic cells (115). IL-6 can reach 
up to 100-fold concentrations in the blood after intense exercise and is capable of 
crossing the BBB (116, 145). IL-6 is also directly upregulated in the hippocampus 
following exercise, and has been found to regulate both cognition and 
neurogenesis (146). 
Other examples of inflammatory mediators serving as neuromodulatory exercise 
factors are CXCL12, a chemokine implicated in learning and memory, IL-8, a 
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cytokine involved in regulating neurotransmission and synaptic plasticity, and IL-
15, a cytokine with an important role in adult neurogenesis (147). 
Adiponectin 
More than two decades ago adipose tissue was discovered to be an endocrine 
organ, with many hundreds of adipokines being released into the circulation 
capable of affecting a range of physiological processes in the body (1). 
Adiponectin is an example of an adipokine, which has insulin-sensitizing, anti-
inflammatory, anti-atherogenic properties and neuroprotective effects (112). 
Adiponectin is increased in the circulation from exercise and can pass through the 
blood–brain barrier to induce cell proliferation and anti-depressive effects, 
suggesting that adiponectin is involved in mediating the effect of exercise on 
hippocampal neurogenesis and depression (112). 
Hepatokines 
Liver also releases hepatokines with endocrine effects that regulate glucose and 
lipid homeostasis (148). Several hepatokines are known to be involved in organ 
cross-talk. For example, hepatokines such as IGF-1 and FGF-21 may mediate 
crosstalk between the liver and brain in response to exercise.  
IGF-1 is an important metabolic regulator, primarily with insulin-sensitizing 
effects. It is produced in the liver, muscle, and the brain (148). IGF-1 crosses the 
BBB to mediate neuroplasticity and neuroprotection. IGF-1 upregulates BDNF 
expression in the hippocampus, increases the number of newborn neurons in the 
DG, and restores abilities to perform hippocampus-dependent tasks (149, 150). 
Blockade of circulating IGF-1 using antiserum inhibits the exercise-induced 
increase in adult hippocampal neurogenesis (108, 149), indicating that exercise-
induced effects on the brain rely on an increased uptake of IGF-1 from blood into 
the brain. 
Systemic FGF-21 is released from the liver during exercise, having a role in 
regulation of metabolism mediated in part by acting on the CNS (1). FGF-21 is 
induced through the PPARα and PGC-1α pathways, and can cross the BBB. FGF-
21 has also been shown to prevent cognitive decline in obese insulin-resistant rats 
by improving hippocampal synaptic plasticity and brain mitochondrial function 
(151). 
Ketone bodies 
The formation of ketone bodies has recently been shown to play an important role 
in the effects of exercise on the brain. Ketone bodies are markedly increased in 
the circulation and brain after fasting, dieting and intense exercise (1). Under 
conditions of reduced glucose levels, such as prolonged exercise, excessive acetyl-
CoA is redirected into formation of ketone bodies, such as acetoacetate and β-
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hydroxy acid (BHA), to serve as an energy source in the body. BHA crosses the 
blood-brain barrier, accumulates in the hippocampus, which increases expression 
of BDNF through HDAC inhibition (110), and can act as a neuroprotectant in 
experimental models of Huntington and Parkinson disease (1). 
Exercise-induced changes in muscle and PGC-1α 
Physical exercise impacts the entire body, but the organ that is activated most 
strongly by the energy demanding mechanical work is the skeletal muscle system. 
Muscle is a regulator of whole-body energy metabolism and an endocrine organ 
producing and releasing factors that have vital roles in communication with other 
organs (152). After an acute bout of exercise, muscle cells respond with a robust 
upregulation of metabolism-related genes. Skeletal muscle undergoes adaptations 
from regular aerobic exercise that lead to improved energy metabolism, 
mitochondrial density, oxidative capacity, fatty acid oxidation, glucose uptake, 
angiogenesis, and muscle fiber-type switching (2, 153). 
Skeletal muscle is a heterogeneous mixture of different types of myofibers 
classified on the basis of specific myosin heavy-chain isoform expression. Type I 
myofibrils are slow-twitch fibers, due to their slow contraction time to peak 
tension, and type II fibers fast-twitch with quicker contraction but rapid fatigue 
profile (154). Of the main fiber types in rodents, type I and IIa exhibit high 
oxidative potential and capillary supply, while IIb are primarily glycolytic. 
Exercise activates adaptations in skeletal muscle dependent on the type of exercise 
performed. While aerobic/endurance exercise promotes increased mitochondrial 
biogenesis, oxidative capacity, and glycolytic-to-oxidative fiber-type switching, 
anaerobic/resistance exercise promotes hypertrophy and oxidative-to-glycolytic 
fiber-type switching (19). Endurance exercise mainly leads to a switch in fiber 
type from fast-twitching, glycolytic type IIb fibers to more oxidative, slow-
twitching type I fibers. 
Muscle contractions leads to many intracellular signals (e.g. increased 
sarcoplasmic calcium, increased AMP/ATP ratio, increased ROS levels, and 
increased NAD+/NADH), activating several signaling pathways such as calcium-
calmodulin-dependent kinases, calcineurin, mitogen-activated protein kinases 
(p38 MAPK, ERK1/2), PGC-1α, and PPARα/γ/δ (19, 154), see Figure 6. 
Sarcolemma Ca2+-signaling through calcium/calmodulin-dependent protein 
kinases (CaMKII and CaMKIV) and calcineurin A (CnA) activation lead to 
phosphorylation and activation of p38 MAPK, MEF2, and ATF2, which interact 
with binding sites of PGC-1α promoter to upregulate PGC-1α transcription. 
Another activation pathway occurs through the generation of AMP by the 
hydration of ATP and ADP, sensed by AMPK, which in turn induces and 
phosphorylates PGC-1α. Yet another activation pathway occurs through 
modulation of NAD levels, which activate SIRT1 through deacetylation and 
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regulate important post-translational modifications of PGC-1α. Further, 
accumulation of free radicals in the skeletal muscle from exercise, sensed by via 
ROS/RNS ratio, signals that the antioxidant system should be turned on by 
activating PGC-1α.  
Figure 6. Signaling pathways from exercise in skeletal muscle with 
downstream effects such as mitochondrial biogenesis and angiogenesis. PGC-
1α is activated by p38 MAPK, CaMK/CnA, AMPK, and SIRT1. P38 MAPK and 
CaMK/CaN also induces transcription of PGC-1α through activation of nuclear 
factors such as MEF2 and ATF2. PGC-1α mediates myocellular adaptations to 
exercise by interacting with NRF-1/2, ERRα, and PPARs. 
The transcription factor PGC-1α is a master regulator of mitochondrial biogenesis 
that mediates many exercise adaptations in skeletal muscle including enhanced 
oxidative capacity, antioxidant factors, fatty acid oxidation, glucose uptake, 
angiogenesis, and muscle fiber-type switching (2, 153), as well as the release of 
neurotrophic factors into the blood stream, such as growth factors, hormones, 
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cytokines and metabolites (2, 144, 155). In loss of function studies, PGC-1α 
knock-out mice have a lower ratio of oxidative to glycolytic muscle fibers, lower 
number of mitochondria, reduced oxidative capacity, and reduced endurance 
capacity (154). Even though PGC-1α is not essential for exercise-induced 
mitochondrial biogenesis or fiber type change in skeletal muscle (156), it seems 
to be essential for exercise-induced angiogenesis (157). 
Exercise induces PGC-1α expression also in various areas of the brain with PGC-
1α being involved in neuronal differentiation and function, through the formation 
and maintenance of neuronal dendritic spines (1, 3). PGC-1α has also been 
reported to mediate neuroprotection in animal models of neurodegenerative 
disease and cerebral ischemia (128). 
Exercise, muscle regeneration and metabolism are all linked to inflammatory 
mechanisms. Overexpression of PGC-1α has an inhibiting effect on NFkB (158), 
resulting in an anti-inflammatory pattern of cytokine expression and upregulated 
anti-oxidant defense. 
MCK-PGC-1α 
Transgenic mice with skeletal muscle-specific PGC-1α overexpression under the 
muscle creatinine kinase promoter (MCK-PGC-1α) display a constitutive 
endurance exercise phenotype, with increased mitochondrial density, oxidative 
capacity, and vO2max, as well as improved lipid oxidation, glycolytic-to-
oxidative fiber-type switching, resistance to muscle fatigue, and increased 
endurance exercise performance (153, 155, 159-161). While PGC-1α expression 
is induced in skeletal muscle and brain of exercising mice (3, 162), MCK-PGC-
1α transgenic mice have chronic overexpression of PGC-1α in skeletal muscle, 
but no upregulation in the brain (163). Transcripts for several myokines are 
upregulated in skeletal muscle of MCK-PGC-1α animals, including Fndc5, Vegf, 
Bdnf, Ctsb (cathepsin B), and Il15 (2, 120, 122). Interestingly, irisin, as well as 
BDNF, and IL-15, circulates at 2-fold higher levels in MCK-PGC-1a mice 
compared to wildtype (122). 
In skeletal muscle, MCK-PGC-1α mice show protection from denervation- and 
fasting-induced muscle atrophy (164, 165), as well as Duchenne muscular atrophy 
(166, 167). PGC-1α expression in skeletal muscle has been reported to decrease 
with age in both rodents and humans (168, 169), with MCK-PGC-1α mice having 
improved muscle mitochondrial function in aging, and a muscle gene expression 
profile similar to that of young mice (170, 171). MCK-PGC-1α animals are 
protected from age-related motor dysfunction (163, 171) and have a slightly 
increased life span (170). Further, PGC-1α mediates mitochondria-dependent 
recovery in a mouse model of accelerated aging (172, 173), in which muscle-
specific overexpression of PGC-1α was able to ameliorate both age-related 
mitochondrial dysfunction in muscle, as well as age-related signs of anemia (174). 
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Systemically, MCK-PGC-1a mice have improved kidney energy metabolism with 
protection against kidney damage and fibrosis, an effect that was found to be 
mediated by circulating irisin (122). In the brain, MCK-PGC-1α mice show 
protection from stress-induced neuroinflammation associated with depression 
(138). Due to anabolic effects in the form of accumulation of lipid and glucose, 
along with inhibited glycolysis, sedentary MCK-PGC-1α mice are more 
susceptible to fat-induced insulin resistance (160, 175). However, when 
exercising MCK-PGC-1α mice are subjected to a high-fat diet, this instead 
enhances weight loss and whole-body glucose homeostasis (176). In the same 
manner, both skeletal muscle-specific overexpression of related transcription 
factors, PPARδ (177) and ERRγ (178) have also failed to protect against diet-
induced metabolic derangement. 
AMPK and PPARδ skeletal muscle activation 
AMPK is a key regulator of glucose metabolism and exercise-induced adaptations 
in muscle (19). AMPK is activated by low AMP to ATP ratio, which occurs during 
exercise in humans, triggering PGC-1α-dependent muscular adaptations to 
aerobic exercise such as glycolytic-to-oxidative muscle fiber-type switching and 
improved mitochondrial energy capacity. AICAR, an activator of AMPK, and 
voluntary exercise have similar effects on muscle metabolism, despite no energy 
being expended, with both treatments reliably upregulating PGC-1α expression 
(179). However, AICAR does not mimic all the exercise-induced effects in the 
body as it failed to increase VO2max in rats, casting doubt on the exercise-
mimicking claims of the AICAR model (180). Kobilo and colleagues studied the 
effects of hippocampal neurogenesis and hippocampus-dependent learning by 
intravenous injections of AICAR and GW501516 (GW) (119). Both treatments, 
but more so AICAR, had an effect on spatial memory and hippocampal 
neurogenesis at 1 week. AICAR treatment-induced enhancement of memory 
function was precluded by muscle-specific AMPK α2-subunit deficiency (181), 
indicating that AICAR-induced effects on the brain are primarily due to crosstalk 
between muscle and brain. In an experiment comparing the exercise effect and 
AICAR, Guerrieri and van Praag found that the action of both treatments resulted 
in increased proliferation in the DG and BDNF expression in the hippocampus 
(Guerrieri and van Praag 2015). However, the CNS effect of AICAR was lost at 
after 2 weeks of treatment and genes related to oxidative stress and inflammation 
were upregulated in skeletal muscle at this time point. This indicates that AMPK-
activation likely can have positive short-term effects, but no or even negative 
long-term effects (182). There are off-target effects due to AMPK receptors in 
other tissue types and the brain could be particularly sensitive to extended 
activation of AMPK (183).  
A physiological effect of endurance exercise is to improve fatty acid oxidation 
(19) to delay the depletion of glucose as the primary energy source. PPARδ is a 
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key regulator of substrate utilization, also regulated by AMPK, which increases 
fatty acid oxidation and represses glycolytic genes in muscle to slow glucose 
consumption and maintain glucose levels during exercise. Pharmacological 
PPARδ activation by the agonist GW yielded animals with improved exercise 
capacity, increased insulin sensitivity, and resistance to diet-induced obesity 
(179). When administering a higher dose of GW for longer duration, animals were 
able to run for longer periods due to higher availability of glucose in the 
circulation (184). However, GW treatment did not induce changes in muscle 
usually occurring with exercise such as increased mitochondrial density, 
improved vascularity, or fiber-type switching. GW treatment has been found to 
improve hippocampal neurogenesis and spatial memory, but not as strongly as 
AICAR (119). Since GW is unable to cross the BBB, it likely exerts its effects 
indirectly through muscle-brain cross-talk (109, 119, 179).  
Finally, it should be noted that studies using transgenic animals and 
pharmacological manipulation have shown that many regulators involved in the 
muscle activation cascade are sufficient for upregulating mitochondrial 
biogenesis, substrate utilization, and fiber-type transformation, even though many 
are not essential for exercise-induced muscular adaptations (154). This indicates 
that there are numerous redundancies in the signaling network for exercise-
induced skeletal muscle adaptations, which is likely of evolutionary importance. 
Cranial irradiation 
Cranial radiation therapy is an important treatment modality for brain tumors and 
other forms of cancer. However, the treatment often results in long-term 
irreversible cognitive deficits, especially for the juvenile brain, which in part is 
caused by irradiation-induced reduction in hippocampal neurogenesis (185). 
Cranial irradiation is effective at eradicating cells with prominent proliferative 
capacity, such as tumor cells, but stem and progenitor cells in the hippocampus 
are also severely affected (186). Irradiation also induces vascular abnormalities, 
demyelination, and white matter necrosis (187). Irradiation causes DNA strand 
breaks, interferes with cell-cycle regulatory proteins and leads to apoptosis (188). 
Furthermore, irradiation creates a hostile microenvironment in the brain tissue 
with neuroinflammation, microglia activation, pro-inflammatory cytokine release, 
oxidative stress, and reduction of neurotrophic factor (185, 189). Physical exercise 
can counteract irradiation-induced changes by attenuating neuroinflammation 
(82), upregulating trophic support (190), restoring neurogenesis, and improving 
learning and memory (191). 
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Cortical stroke 
Ischemic stroke is a major cause of mortality and disability worldwide (192). 
Aerobic exercise reduces the risk for ischemic stroke and can improve functional 
and morphological recovery after stroke (21, 193).  
Ischemic stroke starts with necrosis, apoptosis and inflammatory reactions, 
leading to disruption of the BBB, neuroinflammation and oxidative stress, which 
aggravates the primary ischemic tissue damage (194). Also, peri-infarct 
depolarization, excitotoxicity, and apoptosis, are important causes of cell death 
following ischemia (195). Early central events include the production of ROS, 
proteolytic enzymes, pro-inflammatory cytokines, chemokines, and vascular 
adhesion molecules (194). Exercise can prevent secondary ischemic damage by 
inhibiting pro-inflammatory cytokine release, activation of microglia and 
astrocytes, and reduction of leukocyte recruitment into the brain parenchyma 
(194). 
Even though astrocytes and immune cells contribute to the secondary tissue 
damage, they are also important for limiting ischemic injury and promoting 
regeneration. Astrocytes are important for maintaining brain homeostasis and 
preserving the BBB (194). Astrocytes contribute to recovery by inducing 
angiogenesis, neurogenesis and secretion of trophic factors. Microglia and blood-
borne macrophages are rapidly recruited and activated. They acquire either a 
classic pro-inflammatory or an alternative anti-inflammatory profile, by 
scavenging of cell debris and releasing neurotrophic factors, which promote 
neuronal survival and plasticity (194). 
BDNF is released in the brain tissue after stroke (196) which improves 
mitochondrial metabolism and plays a critical role in repair processes (194), with 
exercise being able to promote the release of neurotrophic factors, including 
BDNF, after brain ischemia (194).  
Importantly, exercise also ameliorates ischemia-dependent reduction of 
mitochondrial biogenesis (197). These PGC-1α mediated exercise-inducible 
changes may have an impact on oxidative stress and mitochondrial biogenesis-
dependent recovery after CNS insults, such as ischemic stroke (198). 
Cerebral blood flow is influenced after stroke due to impairments in vasomotor 
reactivity (77). To ensure a proper delivery of oxygen and nutrients the vasomotor 
capacity needs to be restored. Exercise leads to vascular remodeling, 
vasorelaxation and increased blood flow in the brain parenchyma, which lead to 
improved tissue regeneration, as well as short- and long-term functional recovery 
after stroke (80, 196). Exercise reduces infarct sizes and neurological sequel in 
middle cerebral artery occlusion (77), due to VEGF-mediated increase in cerebral 
blood flow (80).  
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Aging 
Adult hippocampal neurogenesis gradually diminishes with age, a deterioration 
process considered to contribute to age-dependent cognitive decline (199, 200). 
Mechanisms behind this age-related effect include low-level systemic 
inflammation, neuroinflammation with microglial activation, mitochondrial 
dysfunction, oxidative damage, telomere dysfunction, genomic instability, 
dysfunction of the BBB, reduced cerebral blood flow, abnormal protein 
accumulation and phagolysosomal function, reduced trophic support, depletion of 
quiescent neural stem cells, shift from neuronal to astroglial commitment of neural 
stem cells, and decreased neuroplasticity (201-203). All of the above mentioned 
changes have been reported to be directly or indirectly ameliorated by exercise 
(204). In animal models, exercise has been observed to prevent age-related decline 
in neurogenesis (62), as well as to enhance angiogenesis, synaptogenesis, and to 
upregulate several neurotrophic factors (31). Exercise attenuates age-dependent 
decline in neurogenesis (58) by maintaining the hippocampal stem cell pool 
during aging and promoting neuronal lineage commitment of NSPCs (205). The 
PGC-1α pathway plays a part in exercise-induced effects in the brain by regulating 
mitochondrial biogenesis, oxidative capacity, and ROS production in the CNS (3, 
162, 206), and as a consequence, mitochondrial biogenesis-dependent recovery 
may impact age-dependent decline in hippocampal neurogenesis (207). Similar to 
exercise, PGC-1α overexpression is also known to modulate many of the 
processes of aging, such as inflammatory cytokine profile, telomere dysfunction, 
mitochondrial dysfunction, oxidative stress, insulin resistance, and genomic 
instability (208). Further, aging reduces exercise-induced adaptations in the 
muscle, with diminished induction of PGC-1α, NRF-1, and cytochrome c (209), 
to levels comparable to that of PGC-1α knock-out mice. The age-related changes 
in muscle can be ameliorated by overexpression of PGC-1α in muscle, which 
appears to rejuvenate aging tissue and enhance a subset of young-like molecular 
patterns (170). 
The regenerative potential of tissue-specific stem cells diminishes with age (199, 
210), and loss of regenerative capability contributes to loss of tissue function 
(211). Thus, by improving regeneration, tissue function could be improved. 
Enhancement of aged stem cell functions can be accomplished either by 
restoration of stem cell-intrinsic characteristics or restoration of the 
microenvironment (210, 211). Transplanting muscle cells from aged animals into 
young animals restores their regenerative capacity, but transplanting muscle cells 
from young animals into aged animals reduces their regenerative capacity (212), 
leading to the notion that systemic factors could influence the microenvironment 
of the stem cell niches (211). By reducing the inflammatory environment, neural 
stem cells are thought to be revitalized (201). Therefore, targeting the systemic 
 INTRODUCTION  27 
environment could be an effective approach to improve stem cell regeneration and 
tissue function. 
Exercise is one such strategy that works to improve stem cell functions by an 
increase in autophagy, protection from metabolic stress, increase in telomere 
lengths, counteraction of telomere shortening, and promoting neuronal lineage 
differentiation (204, 205). Another treatment strategy is ‘young blood’ that has 
recently been reported to rejuvenate many organs including the brain, with 
improved hippocampal function at a molecular, cellular, structural, and behavioral 
level. Transfusion of blood or plasma from young mice, or umbilical cord, into 
aged mice increases neurogenesis, reduces microglial reactivity, and improves 
learning and memory (201, 213). Several anti-aging factors have been identified 
in young blood, such as TIMP2 and GDF11, which, through systemic 
administration, have been found to improve synaptic plasticity, hippocampal 
neurogenesis, and cognitive functions in aging (201, 213). Likewise, the 
disruption of the vascular structure and cerebral blood flow has been reported to 
be able to recover in aged parabionts exposed to young factors (213). Several 
studies have also observed positive effects in various tissue and injury models 
through local and systemic administration of mesenchymal stem cells (214). It is 
possible that factors in blood regulated by aging also are regulated by exercise. 
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AIMS 
In this thesis we sought to determine if muscle-derived exercise-induced signaling 
via PGC-1α muscle activation influences neuroplasticity under physiological or 
pathophysiological conditions and if factors are released into the circulation that 
contribute to exercise-induced effects on the CNS. 
These specific aims were addressed: 
• To determine if muscle-specific PGC-1α overexpression can ameliorate 
irradiation-induced decline in neurogenesis or improve morphological 
outcome in cortical stroke (paper I). 
• To determine if muscle-specific PGC-1α overexpression contributes to 
exercise-induced neurogenesis in aging, and if this contribution is sex-
dependent or enhanced in a running wheel paradigm (paper II and paper 
III). 
• To determine if serum-induced changes from exercise and muscle-
specific PGC-1α overexpression, or conditioned medium from PGC-1α-
overexpressing muscle cells, can influence the behavior of neural stem 
cells (paper IV). 
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METHODOLOGY 
In this chapter the rationale for the methodology used in this thesis is outlined. 
See the Methods sections in the corresponding thesis papers for detailed 
descriptions of the methods. 
Animal models 
Transgenic animals and genotyping 
Transgenic MCK-PGC-1α animals on C57BL/6J background have been 
previously described (153). Female C57BL/6J mice were used for breeding 
purposes. Transgenic animals were bred as hemizygous mice and wild type (WT) 
C57BL/6J) littermates were used as controls. Animals were housed at a constant 
temperature (24°C) with 50-60% relative humidity. A 12-h light/dark cycle was 
maintained with lights from 07:00 to 19:00 and with ad libitum access to food and 
water. All experiments were approved by the Gothenburg ethical committee on 
animal research (#317-2012 and #181-2015) and performed in accordance with 
relevant guidelines and regulations. Genotyping was performed as described by 
the donating investigator (Bruce Spiegelman, Harvard University, Boston) in the 
Jackson Laboratory database (Stock no. 008231).  
Comments: 
Muscle-specific overexpression of PGC-1α in a transgenic mouse model yields a 
chronic activation of skeletal muscle cells with an improved muscle function and 
an endurance exercise phenotype. We used both young (3-month-old) and older 
(11-month-old) animals of both sexes for the projects. Young male animals were 
used for irradiation and stroke (paper I). Young female animals were used for the 
running experiment (paper III). Older male and female animals were used for the 
aging and running experiments (paper II and paper III). 
MCK-PGC-1α animals were originally created by injection of transgenic 
construct containing the PGC-1α gene under the control of muscle creatine kinase 
promoter into fertilized C57BL6 mouse oocyte in Bruce Spiegelman’s lab and 
bred as hemizygotes (153). Mice that are hemizygous for the transgene are viable, 
fertile, normal in size and do not display any gross physical or behavioral 
abnormalities. Animals display a clear redness of skeletal muscle that allowed 
easy identification of the phenotype, see Figure 7. 
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Figure 7. Oxidative muscle phenotype of transgenic MCK-PGC-1α mice. 
Image shows (A) a dorsal view of WT and transgenic MCK-PGC-1α (TG) 
animals, morphology of (B) hindlimb and (C) gastrocnemius/soleus (asterisk) 
muscle. The more intense red coloring of the transgenic muscles is due to the 
higher level of oxygen transporter protein myoglobin, associated with higher 
mitochondrial density. Image reprinted from (153) with permission from Springer 
Nature. 
Genotyping was performed preferably before weaning. Pups were sedated by 
isoflurane anesthesia and earmarked. DNA extracted from earclippings were used 
in PCR with primers for detection of both an internal C57BL6 control gene (384 
bp) and for the transgene insert (168 bp). Animals that had the transgene insert 
were identified as transgenic animals and the animals that did not have the 
transgene insert were identified as wildtype, see Figure 8. 
Comments on aging: 
Mice have been used extensively in experimental research as a mammalian model 
for humans. Mice and humans reach reproductive age at 35-50 days and 13 years, 
with maximum life span being 4 and 120 years, respectively (215). At an age of 
30 months, 50% of C57BL/6 have died, which would correspond to an age of 
approximately 70 years in humans. The ages of young adult mice at 3 months and 
older animals at 11 months used in paper II and paper III, would correspond to 
teens and fifties, respectively (216). Although senescent changes begin in middle 
age in mice (10-15 months) markers of aging are not present (216). The age 
difference used in our aging studies was sufficient to observe significant decline 
of neurogenesis with age, even though the difference would have been greater at 
an even higher age.  
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Figure 8. Electrophoresis gel from genotyping of MCK-PGC-1α mice. 
Irradiation procedure 
In paper I, male 4-month-old mice were anesthetized with an intraperitoneal 
injection of tribromoethanol. The head was covered with a 1 cm tissue-equivalent 
material to ensure an even irradiation dose into the underlying tissue. Whole-brain 
irradiation was administered as a single dose of 4 Gy using a linear accelerator. 
The sham-irradiated control mice were anesthetized but were not subjected to 
irradiation. After irradiation, the animals were returned to their home cages. 
Animals received daily intraperitoneal injections with BrdU from day 3 to 8 post-
irradiation, and were euthanized and perfused 28 days after irradiation. 
Comments: 
A linear accelerator produce megavoltage x-ray beams by the deceleration of 
electrons in a tungsten alloy (217). Ionizing radiation affects all atoms and 
molecules in the cell, but DNA injury is considered to be the most important factor 
for the induction of cell death. Damage to DNA occurs by either breakage in both 
DNA strands due to a single ionization event, or by two single-strand breaks 
happening on the same strand. Cell damage can also take place by the formation 
of free radicals, by the ionization of other molecules that indirectly exerts toxic 
effects on DNA. The most radiation-sensitive cells are those that are 
undifferentiated and quickly dividing, such as stem cells, progenitors, and cancer 
cells. The absorption of energy to tissue is measured in Gray (Gy) units, where 1 
Gy corresponds to 1 Joule/kg. 
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Photothrombotic stroke procedure 
In paper I, male 3-month-old mice were subjected to a photothrombotic stroke in 
the sensory-motor cortex area. The lesion was induced by peritoneal injection of 
Bengal rose and an infrared laser beam aimed at the exposed skull. After the 
procedure animals were returned to their cages. Animals were given daily 
intraperitoneal injections with BrdU from post-lesion day 7 to 10, to be euthanized 
and perfused 28 days after stroke. 
Comments: 
The photothrombotic stroke model has both advantages and disadvantages. It is a 
minimally invasive method, with low mortality and highly reproducible cortical 
lesions (218). The model induces an end-capillary thrombosis that leads to a well-
defined lesion and a marginal penumbral zone. This clear border can facilitate the 
study of cellular responses within the ischemic or intact cortical area. Similar to 
artery occlusion in naturally occurring thromboembolic stroke, platelet 
aggregation and clot formation interrupt blood flow in the laser-illuminated area. 
However, thrombosis in human stroke is caused by interruption of blood flow in 
a single artery, whereas photothrombosis produces simultaneous clotting in a large 
number of blood vessels within the illuminated area. Thus, collateral blood supply, 
which normally is capable of preventing necrotic cell death in the penumbra, is 
hindered in photothrombosis. The penumbra is the main target of post-ischemia 
neuroprotective agents, which makes the photothrombotic stroke less ideal for 
studying these agents. Also, photothrombotic stroke does not lead to reperfusion-
injury as can occur in human stroke, and to study this type of injury a transient 
occlusion model is more appropriate. Further, photothrombotic stroke may not be 
adequate to study anti-thrombotic agents due to the fact that photothrombotic 
infarction occurs despite blocking platelet aggregation and inhibition of the 
intrinsic coagulation pathway (219). 
Voluntary running 
In paper III, female and male wildtype and MCK-PGC-1α mice at 2 and 10 
months of age were single-housed in cages with free access to locked low-profile 
running wheels. In paper IV, male and female mice at ages of 7-10 months, were 
acclimatized with locked low-profile running wheels in groups of 2-4 animals per 
cage (single-housed for males) for animals whose serum was used in proliferation 
and differentiation assays, and single-housed for females used in RT-qPCR 
experiment. After 5 days, running wheels were unlocked for half of the animals, 
and the running activity was wirelessly monitored for each cage throughout the 
experiment. Wildtype and transgenic animals were randomly assigned to 
voluntary running or to the sedentary control group. All animals were euthanized 
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and perfused 28 days after the first day of irradiation, stroke, or start of BrdU 
injection. 
Comments: 
Forced exercise models such as swimming and treadmill running results in a 
higher degree of standardization in an exercise paradigm compared to voluntary 
running. However, forced exercise results in anxiety-like behavior and higher 
cortisol levels compared the voluntary running (220). Voluntary, or ‘natural’, 
running is characterized by fast-paced running during shorter periods, whereas 
forced running involves a shorter pace of running for longer periods. In voluntary 
running, it is important to use locked running-wheels as a control, since the 
presence of a locked running wheel can be sufficient to induce proliferation in the 
SGZ (221).  
BrdU labeling 
Animals were injected with BrdU in order to investigate survival of newborn 
neurons, as well as determining the ratio of newborn neurons to glial cells.  
In paper I, we injected animals intraperitoneally with BrdU (50mg/kg) between 
post-irradiation day 3 and 8, as well as between post-stroke day 7 and 10. In paper 
II, group-housed male and female WT and transgenic (TG) mice were given daily 
intraperitoneal injections of BrdU for 5 consecutive days at 2 or 10 months of age. 
In paper III, after 5 days of acclimatization, half of the running wheels were 
unlocked and animals were given daily intraperitoneal injections of BrdU for 5 
consecutive days. 
Comments:  
BrdU is a synthetic thymidine analog that gets incorporated into the DNA of 
mitotic cells during the S-phase over a period of 2 hours (222). The molecule is 
administered to date birth of cells and report their fate through co-labeling with 
other markers. BrdU does not appear to be significantly incorporated during DNA 
repair and is not taken up by dying neurons (223), and therefore provides a good 
measure of proliferation or survival based on the experimental design. 
Phenotyping 
In order to validate the phenotype of MKC-PGC-1α transgenic animals gene 
expression analysis was determined through RT-qPCR, and ratio of nuclear to 
mitochondrial DNA was determined through qPCR, on gastrocnemius muscle 
tissue.  
34  METHODOLOGY
In paper I, male 3-month-old mice were decapitated under isoflurane anesthesia. 
Gastrocnemius muscle was dissected and snap-frozen in isopentane containing 
dry ice to prevent RNA degradation. In paper II, hippocampi, pre-frontal cortex, 
and gastrocnemius muscle, were harvested from 8-month-old males in the same 
manner. In paper IV, cell lysates of transfected myocytes and serum-treated 
NSPCs were harvested in RNAlater. 
RNA or DNA were extracted from muscle, brain tissue, or cell lysates. Purified 
RNA was analyzed for integrity and purity to ensure high quality RNA samples. 
Quantitative PCR was performed according to MIQE guidelines for cDNA and 
DNA. 
Comments: 
Primer design was performed to ensure that cDNA primers targeted exon-exon 
junctions, were transcript-specific, and optimized in silica. All qPCR experiments 
included minus reverse-transcriptase controls for all samples to confirm that no 
genomic contamination had occurred, as well as primer pairs and minus template 
controls for all primer pairs to confirm that no contamination by qPCR reagents 
had occurred. Melt curve analysis was conducted after finishing all PCR cycles to 
confirm that no non-specific amplification had occurred. All primer pairs in qPCR 
experiments were run on standard curves of pooled cDNA samples of 5 dilution 
points in 10-fold steps. From the standard curve reactions, linear detection range, 
error, and amplification efficiency for all primer pairs could be calculated. All 
qPCR experiments were normalized against one or more reference genes.  
Tissue and serum processing 
Four weeks following irradiation, stroke, or start of BrdU-injections, mice were 
deeply anesthetized with a peritoneal injection of thiopental during the inactive 
phase of the animals.  
Animals were transcardially perfused with cold saline solution followed by 4% 
paraformaldehyde (PFA) in phosphate-buffered solution (PBS). The brains were 
immersion-fixed in PFA and subsequently cryoprotected in sucrose solution after 
24h. Left hemispheres were sectioned sagittally, or coronally for stroked animals, 
at 25 μm thickness for immunohistochemistry, using a sliding microtome. 
Sections were stored at 4°C in cryoprotectant solution until use. 
Except for irradiated and stroked animals, blood was extracted for all animals 
through cardiac puncture immediately preceding transcardial perfusion. Blood 
was then allowed to coagulate in a low protein-binding microcentrifuge tube. 
After centrifugation, serum was stored at -80°C until further use. 
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Protein analysis techniques 
Western blot 
Western blot was performed to validate the upregulated protein expression of 
PGC-1α in gastrocnemius muscle of transgenic MCK-PGC-1α mice.  
In paper I, male 3-month-old mice were decapitated under isoflurane anesthesia. 
Gastrocnemius muscle was dissected and snap-frozen. Muscle specimens were 
homogenized by sonication in ice-cold RIPA buffer. Both electrophoresis and 
electrotransfer of proteins were performed under wet and reducing conditions. 
Membranes were rinsed, and blocked with bovine serum albumin. Membranes 
were incubated with rabbit-anti-PGC-1α antibody overnight at 4°C, followed by 
rinsing and incubation with peroxidase-conjugated donkey-anti-rabbit antibody 
for 1 hour at room temperature. After washing with TBS-T, bands were visualized 
by chemiluminescence. 
Multiplex protein analysis 
In paper II-IV, multiplex assays were used to evaluate differences in serum 
protein levels of cytokines, chemokines, and myokines in transgenic MCK-PGC-
1α and endurance trained animals. 
Comments: 
The preferable choice in analyzing the proteome in transgenic MCK-PGC-1α 
animals would have been a mass spectrometry-based method. The difficulty in 
detecting myokines through proteomics is due to a few highly abundant serum 
proteins making up ~99% of the protein content, which interfere with the analyses 
of low abundance proteins in the nano-, pico- or femtomolar range (224). We 
therefore decided to use immunoaffinity-based commercially available multiplex 
assays. 
Immunohistochemistry 
Immunohistochemistry was used to visualize and quantify neurogenesis and 
inflammatory responses, as well as other cellular markers. 
An antigen retrieval step in sodium citrate was performed before 
immunohistochemistry with antibodies against DCX and NeuN. When staining 
for BrdU, sections were incubated in hydrochloric acid and neutralized in borate 
buffer. For all immunostainings, sections were incubated in blocking solution 
containing a detergent and donkey serum. Primary antibodies were diluted in 
blocking solution and free-floating sections were incubated at 4°C for 3 days in 
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goat anti-DCX, 2-4 days in rat anti-BrdU and mouse anti-NeuN, or overnight with 
rabbit-anti-Iba1 and rat-anti-mouse-CD68. After rinsing, sections were incubated 
with corresponding secondary antibodies conjugated to fluorochromes. After 
rinsing, sections were mounted onto glass slides and coverslipped. For 
BrdU/NeuN double stainings, sections were mounted onto glass slides, and after 
being allowed to dry, glass slides were submerged in Sudan Black in EtOH, and 
coverslipped. 
For the immunoperoxidase method, endogenous peroxidase was first quenched 
with hydrogen peroxide. When staining for DCX, an antigen retrieval step was 
performed as described above. After blocking of non-specific binding as described 
above, sections were incubated at 4°C overnight with rat-anti-BrdU, overnight 
with rabbit-anti-GFAP, and 3 days with goat-anti-DCX. After rinsing, sections 
were incubated at RT for 1 hour with corresponding secondary antibodies 
conjugated to biotin. For amplification of the immunoperoxidase signal, sections 
were incubated in avidin-biotin-peroxidase complex. The staining was developed 
in solution containing DAB, hydrogen peroxide, and nickel chloride. Finally, 
sections were rinsed, mounted onto glass slides and coverslipped. 
For Nissl histochemistry, rinsed and mounted sections on glass slides were stained 
with cresyl violet, decolorized in acetate buffer, and alcohol-treated, before 
coverslipping. 
Comments: 
In normal aging brain, and even more so with neurodegeneration, macromolecules 
become oxidized with lysosomes unable to degrade them. This leads to increased 
production of lysosomal proteins and enzymes, and abnormalities in endosomes, 
lysosomes, and autophagosomes (225). One such macromolecular build up from 
lysosomal inefficiency is lipofuscin. For aged tissue, the endogenous lipofuscin 
autofluorescence often needs to be quenched by treatment with a blocking agent 
such as Sudan Black before mounting. 
Imaging and quantification 
Investigator-blinded stereological quantification was performed using a wide-
field microscope and stereological software. For stereological analysis, data from 
lost or damaged sections were estimated as the average value of the two 
anatomically adjacent sections. Nissl-stained sections were used for volumetric 
analysis of brain and lesion sizes. The lesion size was determined by the infarction 
area, consisting of lost and necrotic tissue, and the surrounding peri-infarct, 
defined as an area with a distinct reduction in neuronal density. In order to analyze 
astrocytic response, images for each section containing a lesion site were corrected 
for uneven illumination and normalized to the contralateral caudal site of the 
infarction using image processing software. Multiple single-lined 8-bit intensity 
 METHODOLOGY  37 
measurements radially projecting with fixed angle intervals from the center of the 
infarction were collected and averaged using ImageJ. Quantification of Iba1+- and 
CD68+- cells was performed using systematic random sampling with a counting 
area defined by the fixed radius from the infarct border along with systematically 
distributed counting frames. All Iba1-expressing/CD68-expressing cells were 
localized at the core of the infarction, were non-ramified and amoeboid in shape. 
However, not all amoeboid shaped Iba1-expressing cells were co-expressing 
CD68. The brain volume corresponding to the location of the photothrombotic 
infarct was measured on whole brain sections (including infarct) between the most 
anterior section, interconnecting the corpus callosum, and the most anterior 
section, containing the dentate gyrus. Quantification of DCX+-cells in dentate 
gyrus for irradiated animals, and in cortex and corpus callosum for stroked 
animals, was performed. For area measurement of CD31-stained blood vessels, 
Fiji was used for automatic thresholding with the Huang-algorithm. For analysis 
of NeuN+/BrdU+ co-expression a confocal microscope was used. The total number 
of NeuN+/BrdU+ cells was calculated as the ratio of BrdU+-cells co-expressing 
NeuN+ multiplied by number of total BrdU+-cells in the SGZ and GCL. All images 
were cropped and adjusted for brightness, and confocal images were level adjusted 
for enhanced signal-to-noise ratio per channel. 
Cell culture experiments 
Myoblast cell culture 
Myoblasts derived from the C57BL/6J mouse fetal skeletal muscle were cultured 
as adherent monolayers in collagen coated flasks according to established 
protocols for growth of primary myoblast cultures. For proliferating conditions 
growth media consisted of Ham’s F10 Nutrient Mix, DMEM and fetal bovine 
serum, supplemented with FGF-2 and penicillin/streptomycin. Cells were 
passaged at 80% confluency every 3-5 days for re-plating in collagen coated 
flasks. 
ELISA 
ELISA was used to determine VEGF protein concentration in myocyte lysate and 
conditioned media. 
Twenty-four hours following plasmid transfection of myocytes, cells were 
washed, pelleted, and snap-frozen. Cell membranes were broken by repeated 
freeze-thaw cycles and centrifuged for the collection of supernatant to be used in 
ELISA. Additionally, conditioned media incubated with transfected myocytes as 
described below was used for ELISA. Samples were normalized based on protein 
concentrations and used in a commercially available ELISA VEGF-kit. 
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Plasmid preparation and transfection 
Stab cultures of E.coli containing plasmid DNA of PGC-1α or green fluorescent 
protein (GFP) were streaked on agar plates and incubated. Single colonies of 
PGC-1α and GFP were selected with a sterile pipette and inoculated in liquid 
growth medium. Plasmid DNA of PGC-1α and GFP were extracted and purified 
from bacterial pellet. Correct plasmid DNA sizes were verified by restriction 
enzyme treatment and electrophoresis according to recommendations by the 
supplier. 
Myoblasts were plated and incubated for 24 hours. At approximately 80% 
confluency, cationic lipid-mediated transfection was performed for introduction 
of PGC-1α and GFP plasmid DNA into the myoblasts. Cultures were incubated at 
for 24 hours and transfection medium was replaced with growth medium for 
NSPCs. After 48 hours of incubation, supernatant was harvested and centrifuged. 
Myocytes were rinsed and harvested. Conditioned media and cells were 
immediately frozen in -80°C until further use. 
Neural stem cell culture 
Using pregnant C57BL/6J animals, NSPCs were derived from subcortical cerebral 
brain tissue of separate mouse litters at postnatal day 3. Brain tissue was collected 
by sterile dissection on ice. Tissue was minced and triturated gently by pipetting 
for mechanical dissociation and enzymatic digestion in a solution containing 
papain, dispase, and DNase. Cells were passed through a cell strainer, washed, 
and pelleted. Cell pellet was re-suspended in warm growth media, containing 
Neurobasal A medium supplemented with B27, GlutaMAX and 
penicillin/streptomycin. Growth factors (GFs) consisting of EGF, FGF-2, and 
heparin, were added and cells were seeded in a suspension culture flask and grown 
as neurospheres. Every second day, GFs were added to the neurosphere culture. 
Neurospheres were passaged by pelleting, dissociation, washing, and re-
resuspension in growth medium. 
Comments: 
The defining criteria for a neural stem cell are the ability for self-renewal and 
multipotency, which can be established through clonal expansion and 
differentiation to neurons, astrocytes, and oligodendrocytes. Neurospheres are 
free-floating aggregate cultures containing a heterogenous population of neuronal 
precursor cells with varying degrees of differentiation to neuronal and glial 
lineages, and are likely to contain only a few percent of neural stem cells (227). 
3D cultures, such as neurospheres, are advantaged due to a higher degree of cell-
cell contacts resulting in a more natural pattern of differentiation. The cell-cell 
interactions within neurospheres counteract the maintenance of precursor cells, 
which is the reason why the proportion of stem cells are so low and why cells in 
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the core of the neurospheres tend to differentiate (228). The interaction between 
differentiating cells and precursor cells may expose the stem cells to paracrine 
factors that promote differentiation. 
The yield of NSPCs that result from preparation of SVZ is higher than for SGZ, 
due to a higher abundance of stem-like cells in the SVZ (229). NSPCs from SVZ 
also proliferate faster, compared to NSPCs derived from the SGZ (230). Taking 
cells into an in vitro culture system means a radical and complete change in their 
environment as they are being exposed to artificial nutrients and high 
concentrations of growth factors, which result in regional identities being 
gradually lost when are maintained in culture. For example, hippocampal NSPCs 
in culture lose their ability to generate Prox1-expressing neurons, a marker of 
granular neurons in the dentate gyrus, after a few passages (231). 
Here, we have cultured NSPCs as neurospheres. Another strategy would have 
been to culture NSPCs as adherent monolayers (229, 231), which creates a more 
homogenous population of NSPCs. Further, adherent monolayers have a reduced 
number of cell-to-cell contacts and creates a more even exposure to the culture 
medium. However, adherent cultures are more difficult to generate due to a lower 
yield of NSPCs than for neurosphere cultures (230). 
Stemness assay 
Immunohistochemistry was performed to confirm that neurospheres expressed 
stemness markers. 
Two days after passage, neurospheres were plated on coverslips coated with poly-
L-ornithine. Neurospheres were fixed with PFA, washed, and blocked for
unspecific binding. The cells were incubated with primary antibodies, rabbit anti-
GFAP and goat anti-Sox2 at 4°C overnight. After washing, cells were incubated
with corresponding secondary antibodies conjugated to fluorophores. After
washing, coverslips were mounted on glass slides. Stained neurospheres for the
stemness assay were visualized using an inverted confocal microscope.
Cell proliferation assay 
Two days after passage, NSPCs were seeded in optical bottom microplates. The 
cells were incubated under growth conditions with serum or conditioned medium 
in a series of concentrations as specified. After 48h of incubation, the cell 
proliferation was assessed using a DNA dye combined with a fluorescent 
suppressor of non-viable nuclei. The fluorescence signal was measured in a 
fluorescence microplate reader. A standard curve was produced for direct 
conversion of fluorescent intensity values to numbers of cells per well. 
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Serum for cell culture use 
At the age of 7 to 10 months, male and female mice, were acclimatized with locked 
low-profile running wheels in groups of 2-4 animals per cage (single-housed for 
males) for animals used in proliferation and differentiation assays, and single-
housed for females used in RT-qPCR experiment. For proliferation and 
differentiation assays, serum was thawed and pooled in corresponding groups 
matched for age, sex, and running distances. For RT-qPCR, individual sera from 
sedentary animals and animals with the highest total running distance were used. 
Comments: 
Serum is typically free from platelets, because they are trapped in the fibrin 
meshwork of the blood clot, while plasma is prepared from blood that has been 
prevented from clotting and therefore is considered to be more comparable to 
circulating blood. Serum includes factors such as BDNF and extracellular vesicles 
(exosomes and microvesicles) (232) secreted by platelets during clotting, while 
plasma typically contain platelets, white and red blood cells, and cellular elements 
that affect analytical results. Serum is considered to preserve stability of analytes 
better than plasma, while plasma is considered to be less stable because of cellular 
debris. 
Cell differentiation assay
Two days after passage, NSPCs were plated in an optical bottom microplate 
coated with poly-L-ornithine and laminin. The cells were incubated under growth 
conditions with sera or conditioned media in a series of concentrations as 
specified. Growth medium with growth factors was not included as a control in 
the differentiation assay since that would inhibit differentiation. The 
corresponding medium was replaced every two days. After 7 days, cells were 
fixed with PFA, washed, and blocked for unspecific binding. Cells were incubated 
with primary antibodies rabbit anti-GFAP, goat anti-Sox2, mouse anti-MAP2, and 
mouse anti-MBP, at 4°C overnight. After washing, the cells were incubated with 
corresponding secondary antibodies conjugated to fluorophores. Hoechst was 
used as a nuclear counterstain. 
Systematic analysis was done for comparison across different experimental plates 
with each plate containing all treatment conditions for one biological replicate. 
Fluorescence images of all stained wells were acquired using a high-content 
screening microscope. The morphological analysis and the quantification of the 
different cell types was done after image acquisition using a high-content 
screening analysis software. Circularity, area and signal intensity of nuclear 
staining were used as parameters to identify cells through gating of detected 
objects per plate. Each plate containing all the compared conditions and circularity 
of cells was fixed for all measurements. Area threshold for cells was set high 
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enough in order to exclude pyknotic nuclei and low enough to exclude cell 
aggregates in the cell count. Signal intensity threshold for cells was set low enough 
to exclude pyknotic nuclei in the cell count. Pyknotic nuclei were classified as 
nuclear staining signals with an area less than the minimum for cells, or a signal 
intensity higher than the maximum threshold for cells. For proper identification 
of GFAP+- and Sox2+-cells the negative and bleed-through controls per 
fluorescent channel were used to determine optimal signal threshold. If a GFAP 
signal above a specified signal intensity threshold occurred immediately outside 
the perimeter of the nucleus, the cell would be counted as a GFAP+-cell. If a Sox2 
signal above a specified signal intensity threshold occurred within the perimeter 
of the nucleus, the cell would be counted as a Sox2+-cell. Neurons and 
oligodendrocytes were quantified manually based on morphological phenotype 
and lack of co-labeling with GFAP. 
NSPC gene expression analysis 
Gene expression analysis was performed in order to validate results from 
proliferation and differentiation assays, taking into account the effects of serum 
withdrawal (see Results and Discussion). 
NSPCs were plated in ultra-low adhesion plates. Growth factors were added to the 
media and after 3 days of incubation, growth medium was replaced by mild 
pelleting of cells. Cells were re-seeded on the plates and incubated for 2 more days 
on a rotary shaker to prevent adhesion. After 2 days of growth factor withdrawal, 
cells were pelleted and re-plated in low-adhesion culture plates with addition of 
different types of mouse sera. After 24h, cells were harvested for RNA extraction. 
Statistical analysis 
Data were processed and analyzed in Microsoft Excel and Graphpad Prism. 
Appropriate tests were chosen as specified in the text based on homogeneity of 
variance. Normality and homogeneity of variance was assessed by visual 
inspection of density plots and statistical tests, such as D’Agostino-Pearson’s and 
Levene’s test. 
In paper I and paper II, PCR data were analyzed using the Pfaffl method, taking 
into account ratios and multiple sources of error from normalization and efficiency 
calculations by applying bootstrapping techniques in Qiagen REST 2009. In 
paper IV, PCR data were analyzed using the ΔΔCT method. For matched qPCR 
data, repeated measure ANOVA (one-way RM-ANOVA) was used if matching 
was effective between samples, otherwise ordinary one-way ANOVA with 
Tukey’s post-hoc test for multiple comparisons was used. For data without normal 
distribution, non-parametric RM-ANOVA was used in the form of Friedman’s 
test with Dunn post-hoc correction.  
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For matched cell culture data in paper IV, comparisons of means between two 
groups were analyzed using paired t-test. For repeated concentration-dependent 
measurements, repeated measure two-way analysis of variance (two-way RM-
ANOVA) was used in conjunction with Tukey’s multiple comparisons. One-way 
RM-ANOVA was used in conjunction with a post-test for linear trend to 
determine concentration-dependent effects of mouse serum or conditioned 
medium. 
For comparison of parametric histological data between two groups Student’s t-
test was applied. For histological data adhering to normality and equality of 
variances, two-way ANOVA was used in conjunction with Tukey's post-hoc test. 
For repeated measurements of histological and running data, two-way RM-
ANOVA was used. In paper III, three-way ANOVA was performed in IBM SPSS 
Statistics.  
For multiplex assay analyte data, normality was determined by visual inspection 
of density plotted logged and unlogged data. In paper II and paper III, protein 
concentration data were evaluated by using a two-tailed t-test for normally 
distributed analyte data and Mann Whitney test for non-normally distributed 
analyte data. In paper III, analyte data adhering to normality and equality of 
variances was analyzed using two-way ANOVA in conjunction with Tukey's post-
hoc test. For non-parametric analyte data, the Scheirer-Ray-Hare extension of the 
Kruskal-Wallis test was used as a non-parametric equivalent of the two-way 
ANOVA. Running distances were analyzed against protein concentrations in 
wildtype and transgenic mice using either linear regression for data adhering to 
normality, or Kendall rank correlation for parametric and non-parametric data. 
Linear correlation coefficient and p-values were calculated with Pearson statistics 
using the limma package in R. Kendall rank correlation was used to calculate 
ranking correlation between running distance and cytokine concentrations in 
wildtype and transgenic mice. Kendall’s tau coefficient and corresponding p 
values were calculated based on non-parametric tau statistics. In paper II and 
paper III, all multiplex analyte data was treated systematically without 
discrimination, and false discovery rate (FDR) was calculated with Benjamini-
Hochberg using an online calculator to adjust for multiple statistical analyses. In 
paper I, Cohen’s d and power were calculated post-hoc for t-test regarding 
differences in infarct sizes (independent samples) using G*Power. In paper I, 
statistical outliers were detected as specified in the Results section for the infarct 
volume data set, using ROUT and Grubbs method. We used a significance level 
of 0.05 for all test, except for the rigorous FDR adjustments in paper II where we 
selected a significance level of 0.1. Values were expressed as mean ± standard 
error of the mean (SEM).  
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RESULTS AND DISCUSSION 
In this chapter the main results of the included papers are presented and discussed 
in the order of the specified Aims: 
In paper I, we investigated whether MCK-PGC-1α animals with improved 
muscle metabolism would display an altered response to acute brain insults. In 
particular, we studied morphological outcome, inflammatory responses, and 
neuroplasticity mechanisms, after irradiation and cortical stroke. 
In paper II, we investigated whether MCK-PGC-1α animals with improved 
muscle metabolism would show enhanced hippocampal neurogenesis in aging, 
and if this effect would be sex-dependent. 
In paper III, we investigated whether MCK-PGC-1α animals with an endurance 
muscle phenotype would display different exercise-induced effects on 
hippocampal neurogenesis, and if this effect would be influence by a running 
wheel paradigm. We also investigated whether exercise or muscle-specific PGC-
1α overexpression releases exercise-inducible factors into the circulation that 
could contribute to exercise-induced effects on the CNS. 
In paper IV, we investigated whether exercise or muscle-specific PGC-1α 
overexpression could influence serum-induced neural stem cell responses in vitro. 
We also evaluated the effect of conditioned media from PGC-1α-transfected 
myocytes on neural stem cell responses in vitro. 
Validation of PGC-1α overexpression in skeletal muscle 
First, we validated that the MCK-PGC-1α transgenic mouse model displayed an 
endurance exercise muscle phenotype. In paper I, we observed that MCK-PGC-
1α had upregulated PGC-1α mRNA levels, protein levels, and downstream 
effector genes, such as Fndc5, Vegfb, Il15, and Mb, in skeletal muscle, which we 
detected at levels comparable to previous studies (2, 120, 138), see Figure 9. PGC-
1α-overexpression induces mitochondrial biogenesis and we detected a robustly 
increased ratio of mitochondrial to nuclear DNA copy number in skeletal muscle 
of transgenic animals, which is a good measure of mitochondrial density (233). In 
paper II, we again validated the phenotype of older 8-month-old MCK-PGC-1α 
animals that showed comparable mRNA levels of PGC-1α and downstream 
effector genes, including Timp4 and Ctsb (cathepsin B). We did not evaluate 
mRNA levels of Bdnf, which later has been found to upregulated in muscle of 
MCK-PGC-1α animals (122). 
As discussed in paper III, the protein products of each of these downstream 
effector genes have been identified to be secreted from muscle and to have 
neurotrophic properties.  
44  RESULTS AND DISCUSSION
Figure 9. Validation of PGC-1α overexpression in skeletal muscle. Graph (A) 
shows relative mRNA levels of Pgc1a and downstream effector genes in 
gastrocnemius of 3-month-old animals. Graph (B) shows ratio of mitochondrial 
to DNA copy number relative to wildtype. Image (C) shows western blot on 
pooled samples with antibody against PGC-1α (GAPDH as loading control). 
Graph (D) shows relative mRNA levels of Pgc1a and downstream effector genes 
in gastrocnemius of 8-month-old animals. Data expressed as median, with 
interquartile range as box, with minimum and maximum values as whiskers for 
wildtype and MCK-PGC-1α animals (Pfaffl method, resampling test; n=5-6; *, 
p<0.05; **, p<0.01; ***, p<0.001). 
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Cranial irradiation and Cortical stroke 
Skeletal muscle PGC-1α overexpression does not protect against 
irradiation-induced reduction of hippocampal neurogenesis 
In paper I, using a model of cranial irradiation, we studied the potential protective 
or regenerative effects of chronic muscular overexpression of PGC-1α on 
hippocampal neurogenesis after ionizing radiation (IR). Animals were injected 
with BrdU from day 3 to 8 post-irradiation and analyzed 4 weeks after IR. 
We found that the number of newly generated, BrdU-positive, cells in the 
neurogenic region of the DG, consisting of the SGZ and GCL, was reduced by IR 
treatment without any difference between wildtype and transgenic animals. 
Similarly, DCX-positive immature neurons were reduced by IR, but without 
significant difference with respect to genotypes. In addition, we quantified Ki67+-
cells in the DG that showed a tendency toward irradiation-induced reduction of 
proliferation 4 weeks after IR. The number of newly generated neurons 
determined by NeuN/BrdU co-labeling, was reduced by irradiation treatment 
without any differences between the genotypes, see Figure 10. Furthermore, the 
number of newborn cells in the DG, ML, and hilus, as well as the regional volumes 
of GCL, ML and hilus, showed no differences between genotypes. 
The sensitivity of immature neurons to irradiation increases as a function of age 
(234). By using a cranial irradiation dose of 10 Gy, Andres-Mach et al. found that 
there is an 90% decrease in proliferation within the SGZ and an 80% decrease in 
the number of DCX positive cells within the DG for 4-month-old irradiated 
animals compared to age-matched controls (234). Based on age-dependent decline 
of neurogenesis and age-dependent increase in radiation sensitivity the irradiation 
dose in this study was limited to 4 Gy for 4-month-old mice to have a sufficient 
portion of neural progenitors and immature neurons left to study. However, using 
this dose we achieved only a mild decrease in neurogenesis. Therefore, we cannot 
exclude that a higher irradiation dose may have uncovered a difference in post-
irradiation neurogenesis levels between genotypes. 
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Figure 10. Overexpression of PGC-1α in skeletal muscle does not protect 
against irradiation-induced reduction of hippocampal neurogenesis. Images 
show (A) confocal image overview of BrdU+/NeuN+ immunostaining of the DG 
4 weeks after irradiation and (B) confocal image from quantification, with 
corresponding graph (C) showing total number of NeuN+/BrdU+ cells in the 
combined area of SGZ and GCL (see Methodology section for calculation). Data 
expressed as mean ± SEM for sham and irradiated animals (two-way ANOVA; 
n=7-8; *, p<0.05; **, p<0.01). Scale bars = 20 µm. IR, ionizing radiation; SGZ, 
subgranular zone; GCL, granular cell layer. 
Skeletal muscle PGC-1α overexpression does not affect 
neuroinflammatory response and is not favorable for 
morphological outcome after cortical stroke 
In paper I, we investigated the potential protective and regenerative effects of 
chronic muscular overexpression of PGC-1α on the morphological outcome after 
cortical stroke. Animals were injected with BrdU day 7 to 10 after 
photothrombotic stroke and analyzed 4 weeks after stroke.  
With regard to inflammatory responses, stroke-lesioned animals displayed a 
higher density of microglial cells (Iba1+) in the peri-infarct region compared to 
sham-lesioned controls, but no differences existed between wildtype and 
transgenic mice, see Figure 11. There were no significant differences in activated 
microglia between the genotypes as judged by density of CD68+-cells in the peri-
infarct area. Microglial activation index was calculated as the fraction of Iba1+-
cells co-expressing CD68+, which showed no difference between wildtype stroke 
and MCK-PGC-1α stroke group. Reactive astrocytosis was measured as the 
intensity of GFAP expression within the peri-infarct region, which revealed a 
significant treatment effect from photothrombosis on GFAP intensity, 
representative of the astrogliotic response to the injury, but no difference could be 
detected between genotypes.  
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Figure 11. Overexpression of PGC-1α in skeletal muscle does not affect 
microglial response after cortical stroke. Image (A) represents 
immunohistochemical staining of Iba1/CD68 at 4 weeks after photothrombotic 
stroke at the infarct border. Graphs show (B) density of total microglia (Iba1+; 
two-way ANOVA) and (C) activated microglia (CD68+; t-test) in both infarct and 
peri-infarct zones for stroked wildtype and MCK-PGC-1α mice (WT, n=7; MCK-
PGC-1α, n=5) or for sham treatment (WT, n=3; MCK-PGC-1α, n=3). Scale bar = 
20 µm. Data presented as mean ± SEM (****, p<0.0001). 
PGC-1α regulates the antioxidant defense that may play a role in inflammation, 
as oxidative stress can induce an inflammatory response through activation of the 
redox-sensitive NFkB (158). As discussed in paper I, inflammatory response 
after cortical ischemia peaks within a week to gradually diminish afterwards. Even 
though we do not see any impact on inflammatory responses the time point for 
analysis of inflammatory response chosen in this study may have missed potential 
differences in a more acute phase of the inflammatory response. 
We detected increased levels of VEGF mRNA in PGC-1α overexpressing muscle 
tissue. Since VEGF is released into the circulation following exercise and has been 
identified as the most important pro-angiogenic factor in most tissue (116), the 
increased expression in skeletal muscle overexpressing PGC-1α may affect the 
microvascular system in the CNS. However, we found that vascularization in the 
neocortex, determined by the mean vessel density (based on CD31-staining of 
endothelial cells), was unchanged between WT and MCK-PGC-1α. 
In terms of morphological outcome, transgenic mice had on average 57% greater 
infarct volume in comparison to the wildtype group, see Figure 12. There was no 
difference in brain volume between the two groups, and the relative amount of 
necrotic tissue loss to brain volume was also significantly higher in the MCK-
PGC-1α stroke group. The peri-infarct region, defined as an area with a distinct 
reduction in neuronal density, showed no difference between wildtype stroke and 
MCK-PGC-1α stroke group.  
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Figure 12. Overexpression of PGC-1α in skeletal is not favorable for the 
morphological outcome after cortical stroke. Lesion size in wildtype (n=7) and 
MCK-PGC-1α (n=5) mice 4 weeks following photothrombotic stroke. Image (A) 
shows area measurement of infarct size marked with dashed green line performed 
for each section, along with graphs showing a significantly higher (B) volume of 
tissue loss (p=0.02; t-test) and (C) relative tissue loss to brain volume (p=0.03; t-
test) after stroke in MCK-PGC-1α compared to wildtype animals. Scale bar = 50 
µm. Data presented as mean ± SEM (*, p<0.05). 
In paper I we discuss possible mechanisms out of the scope of the study that could 
have led to larger infarcts in PGC-1α animals. For example, the PGC-1α pathway 
is known to increase mitochondrial biogenesis and ROS production after cerebral 
ischemia, which may exacerbate mitochondria-dependent apoptotic processes 
(206). 
In the study we used photothrombosis as a model for cortical stroke (discussed in 
Methodology). We cannot rule out that MCK-PGC-1α animals would have shown 
a different outcome if we instead would have chosen a model producing a larger 
penumbra, such as transient or permanent middle cerebral artery occlusion, or a 
re-perfusion injury model of vasoconstriction, such as intracerebral injection of 
endothelin-1. 
We did not investigate behavioral outcomes after irradiation or photothrombotic 
stroke in the MCK-PGC-1α animals. Even though it neuroanatomically is 
unlikely, we cannot exclude the possibility that transgenic animals would have 
more or less motor deficits after stroke to the motorsensory cortex. 
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Aging and Voluntary running 
Skeletal muscle PGC-1α overexpression does not protect from 
age-dependent decline in neurogenesis 
In paper II, we investigated the potential longitudinal protective effects from 
chronic muscular overexpression of PGC-1α on hippocampal neurogenesis in 
aging along with possible differences between the sexes. In this study, group-
housed female and male animals were injected with BrdU during 5 days and 
analyzed 4 weeks later. 
We found that the number of BrdU+-cells in the GCL was substantially decreased 
with aging in both WT and transgenic animals of both sexes, but no difference 
existed between genotypes or sexes. Similarly, the number of newly generated 
mature neurons determined by NeuN+/BrdU+ co-labeling decreased with aging 
without any differences between either genotype or sex for 3- and 11-month-old 
animals. The number of immature neurons were reduced with aging, but there 
were no significant differences for 3- and 11-month-old animals with respect to 
either genotype or sex. The orientation of DCX+ neural progenitor cells in the DG 
indicates a state of maturity. We analyzed DCX+-cells in 11-month-old animals 
and found no difference in numbers of DCX+-cells with parallel or perpendicular 
orientation between genotypes and sexes, indicating no difference in the 
maturation rate of immature neurons. 
In this study, we have not controlled for estrogen levels in female animals, but 
found no differences in neurogenesis between sexes neither in young nor in older 
mice, which is supported by previous reports (235). 
Even though MCK-PGC-1α mice have been reported to have unchanged levels of 
gene expression for a number of neurotrophic factors in the hippocampus (138), 
MCK-PGC-1α mice are protected from a neuroinflammatory reduction in 
hippocampal BDNF, GDNF, and VEGF, indicating that muscular PGC-1α 
overexpression could mediate exercise-induced protection from stress-induced 
reduction in neurotrophic growth factors in the brain. MCK-PGC-1α animals also 
have upregulated circulating levels of irisin, BDNF, and IL-15, which are linked 
to neuroprotection (122). However, we found no difference in Bdnf gene 
expression between genotypes in the hippocampus or pre-frontal cortex, 
confirming the findings of a previous report (138).  
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Skeletal muscle PGC-1α overexpression is not sufficient to mimic 
running-induced neurogenesis 
In paper III, we investigated potential protective and regenerative effects of 
chronic muscular overexpression of PGC-1α in exercise and aging. Wildtype and 
transgenic female animals were single-housed and subjected to voluntary running 
at 2 and 10 months of age. At start of running, animals were injected with BrdU 
to label newly generated cells to be analyzed 4 weeks later. 
We found that average daily running distance was similar for both young female 
wildtype and transgenic animals, and was reduced in older female wildtype and 
transgenic animals. Compared to females, average daily running distance in males 
was considerably lower in young male animals and was further decreased in older 
male animals. Female mice have been observed to be more active than males and 
tend to run longer distances with higher velocities, but for the same duration, in a 
running wheel (87, 236). One possible explanation of this may be that female mice 
seem have better respiratory abilities with differences in energy metabolism (84). 
We did not observe any difference in voluntary running between genotypes, which 
stands in contrast to the enhanced endurance capacity that these transgenic 
animals have been reported to display. Calvo and colleagues reported that 
overexpression of PGC-1α in muscle greatly improved short-term exercise 
performance in voluntary running, measured by single-housing animals with 
running wheels for 72h, and a forced exercise paradigm (159). In our data, we see 
that voluntary running activity increases substantially over 4 weeks, a period over 
which no difference was detected between genotypes. However, if pushed by 
forced running MCK-PGC-1α mice should outperform wildtype animals due to a 
higher peak oxygen uptake in muscle (159). 
Aging negatively impacts running velocity, representing a decrease in muscle 
mass, muscle strength, as well as more slow-twitch fibers and fibrosis with higher 
age (237). A part of this effect is due to loss of myoregenerative capabilities in 
satellite cells dependent on lost Notch signaling and activated Wnt signaling by 
circulating factors (e.g. cytokines) (238). Bartling and colleagues reported that 
differences in running activity for females and males gradually diminish with age 
(236) and attributed this to age-related changes in metabolism (84) and hormonal
regulation, making exercise capacity in females and males more alike. See paper
III for a discussion on age-related and sex-dependent differences in running
capacity, as well as sex differences in neurogenesis and exercise-induced
neurogenesis.
We found that the number of BrdU+-cells in the SGZ and GCL of the DG was 
decreased with aging and increased by exercise in both wildtype and transgenic 
animals, but no differences existed between genotypes, see Figure 13. The number 
of newly generated mature neurons determined by NeuN/BrdU co-labeling was 
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reduced with aging, but exercise only increased numbers of new mature neurons 
in 3-month-old animals. Numbers of immature DCX+-neurons were reduced by 
aging and increased by exercise for both genotypes. Number of DCX+-cells and 
running distance was not correlated in running 11-month-old animals, male and 
females combined, for either wildtype or transgenic animals. There were 
statistically significant differences in numbers of DCX+ progenitor cells with 
parallel (early) and perpendicular (late) orientation of the lead process in relation 
to the GCL border for female 11-month-old animals between sedentary and 
running animals, but no differences between genotypes were observed. 
Figure 13. Overexpression of PGC-1α in skeletal muscle does not alter 
exercise-induced amelioration of age-dependent decline of hippocampal 
neurogenesis. (A) Images showing BrdU immunostainings of DG for sedentary 
and running 11-month-old females 4 weeks after first BrdU-injection and start of 
running, with corresponding graphs (B, C) representing number of BrdU+-cells in 
the SGZ and GCL for 3- (two-way ANOVA; n=6-10; running effect, ****, 
p<0.0001) and 11-month-old animals (two-way ANOVA; n=6-9; running effect, 
**, p<0.01). (D) Images of NeuN/BrdU immunostainings of DG for sedentary and 
running 11-month-old females with confocal images of co-localized NeuN+/ 
BrdU+-cells with corresponding graphs (E, F) representing number of 
NeuN+/BrdU+-cells for 3- (two-way ANOVA; n=5-9; running effect, ****, 
p<0.0001) and 11-month-old animals (two-way ANOVA; n=6-9; n.s.). (G) DCX 
immunostainings of DG for sedentary and running 11-month-old females with 
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corresponding graphs (H, I) showing number of DCX+-cells for 3- (two-way 
ANOVA; n=6-10; running effect, **, p<0.01) and 11-month-old animals (two-
way ANOVA; n=5-10; running effect, **, p<0.01). Data expressed as mean ± 
SEM. Scale bars = 20 µm. 
Endurance exercise increases proliferation, differentiation (56), and accelerated 
maturation of adult-born DG neurons (73). As expected, we observed a robust 
exercise-induced increase in neurogenesis measured as newborn BrdU+-cells, new 
immature DCX+-neurons, and newly generated mature BrdU+/NeuN+-neurons. As 
for the lack of effect from exercise on new mature neurons in older animals, this 
has previously been described in a study where chronic voluntary wheel running 
prevented age-related decline in proliferation and immature neurons, which 
however did not lead to more newborn mature neurons (62). 
Here, we have investigated changes in neurogenesis after 4 weeks of voluntary 
running. It is however possible that acute or longer-term exercise would have 
yielded different results. Due to the fact that MCK-PGC-1α animals have higher 
peak aerobic capacity it is possible that the result would have been different if we 
had subjected animals to a forced exercise paradigm, pushing the transgenic mice 
to outperform the wildtype animals. However, one study showed a greater 
increase in hippocampal neurogenesis by mild compared to intense forced running 
on a treadmill in rats (88), which can be explained by higher levels of stress from 
intense exercise compared with mild exercise. 
Skeletal muscle PGC-1α overexpression and running-induced 
serum cytokine and myokine profile 
In paper III, we also sought to determine if skeletal muscle activation via PGC-
1α overexpression release exercise-inducible molecules into the circulation that 
contribute to exercise-induced effects on the CNS. To investigate possible 
differences in serum proteins associated with overexpression of PGC-1α in 
skeletal muscle, running, or a combination of both, we housed 11-month-old male 
wildtype and transgenic animals individually and subjected them to voluntary 
running during 4 weeks. After 4 weeks of running, blood was extracted to 
determine levels of cytokines, chemokines, and myokines in serum. Analysis after 
FDR adjustment for analyte data showed that musclin was significantly 
upregulated at 4-fold higher concentration in transgenic serum, in line with a 
previous study on MCK-PGC-1α animals (170), see Figure 14. Several analytes 
that showed significant differences before FDR-adjustments, but only a trend after 
FDR, require confirmation in future experiments. We observed trends toward 
increased levels of myokines and reduced levels of pro-inflammatory cytokines in 
transgenic animals, including upregulation of eotaxin with running, upregulation 
of oncostatin in transgenic animals, and downregulation of MCP-1, MCP-3, IL-5, 
MIP-1beta, and myostatin, in transgenic animals. 
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Musclin was first described over 10 years ago as a myokine closely linked to 
nutritional changes and produced almost exclusively in fast-glycolytic type IIb 
myofibers (239). Subbotina and colleagues reported musclin as an exercise-
responsive myokine enhancing endurance capacity through mitochondrial 
biogenesis (240). On the other hand, musclin has also been described to mediate 
high-fat diet-induced effects such as insulin resistance and hypertension (239). 
We observed trends towards decreased pro-inflammatory cytokines. Cytokines 
and chemokines have complex functions in the brain due to simultaneously being 
mediators of neuroinflammation and neurodegenerative diseases, but also having 
beneficial functions as neuromodulators. Overexpression of PGC-1α in skeletal 
muscle cells in vitro has been reported to downregulate the pro-inflammatory 
genes IL-6 and TNFα. Muscle-specific overexpression of PGC-1α in mice does 
not alter systemic levels of IL-6 and TNFα, but strongly inhibits gene expression 
of pro-inflammatory cytokine IL-12, as well as increases anti-inflammatory 
cytokines CCL1 and TGFβ in skeletal muscle, overall indicating an anti-
inflammatory profile of the PGC1α pathway (158). 
A recent study by Peng and colleagues found that MCK-PGC-1α mice had 
upregulated serum levels of the myokines irisin, BDNF, and IL-15 (122). The 
commercial multiplex assays employed in our study included quantification of 
irisin and BDNF in serum. However, the assay was not sensitive enough to enable 
statistical comparisons between the groups. 
We did not observe any significant effect of exercise on the studied serum 
proteins. This is in accordance with a previous study by Jeon and colleagues, who 
were unable to detect differences in a panel of 50 cytokines in serum of 20-month-
old mice subjected to treadmill running (241). 
Figure 14. Levels of cytokines and myokines in mouse serum. Graphs showing 
protein concentrations of analytes with differences, or tendencies toward 
differences, between genotype and running (n=7-11). WT, wildtype; Tg, 
transgenic; Sed, sedentary; Vex, voluntary exercise. 
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Neural stem cell responses in vitro 
Effect of exercise and muscle-specific PGC-1α overexpression on 
neural stem cell responses 
In paper IV, we sought to determine if skeletal muscle activation via PGC-1α 
overexpression releases exercise-inducible molecules into the circulation that 
contribute to exercise-induced effects on the CNS. Serum from wildtype and 
transgenic mice was harvested following 4 weeks of running to evaluate the 
response of NSPCs in terms of proliferation and differentiation. Harvested 
exercise-conditioned and transgenic sera were added to culture medium without 
growth factors for a 2-day incubation period to investigate the response of NSPCs. 
Initially, we evaluated the effect of sedentary wildtype serum on proliferation of 
NSPCs and found a concentration-dependent effect on proliferation, see Figure 
15. In subsequent experiments, we compared exercise-conditioned and transgenic
sera over a series of concentrations. Similarly, we observed a higher proliferative
response with increasing serum concentrations, but without differences between
exercise-conditioned and transgenic sera.
Figure 15. Proliferative response of NSPCs upon treatment with sera from 
mice subjected to voluntary running or with chronic muscle-specific PGC-1α 
activation. (A-F) Fluorescence images from proliferation assay showing viable 
cells in green after incubation for 2 days in 0.01%, 0.1%, 1% and 10% sedentary 
transgenic serum. Graphs show proliferative response of NSPCs treated with a 
range of serum concentrations from (G) sedentary wildtype animals only (one-
way RM-ANOVA; post-hoc test for linear trend, ****, p<0.0001); n=3 biological 
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replicates) and (H) sedentary or running, wildtype or transgenic, animals (two-
way RM-ANOVA; concentration effect, ****, p<0.0001; treatment effect, n.s.; 
n=4 biological replicates). Dashed line indicates that ‘–GF’ and ‘+GF’ have not 
been included in the statistical analysis. Scale bars = 20um. Values are shown as 
mean ± SEM. *, p<0.05. GF, growth factors; ‘-GF’, culture medium without GF; 
‘+GF’, culture medium with GF; Sed, sedentary; Vex, voluntary exercise; WT, 
wildtype; Tg, transgenic. 
We further evaluated NSPC differentiation as a response to exercise-conditioned 
and transgenic sera. Cell numbers increased with a concentration-dependent effect 
without any difference overall between mouse sera. Concentration-dependent 
effects were observed for astrocytes and oligodendrocytes, but without any 
difference between treatment groups. No concentration or treatment effects 
existed for MAP2+-neurons, Sox2+-progenitors or GFAP+/Sox2+-stem cells. 
To validate our findings, we also investigated the transcriptional response of genes 
involved in cell-cycle regulation and differentiation, including withdrawal of 
growth factors for 2 days. After withdrawal of essential growth components from 
neural stem cells, cell-cycle related genes remain upregulated for 24 hours (242). 
Neuronal fate markers are upregulated within 6-8 hours with DCX being robustly 
upregulated over the first 1-3 days from the start of differentiation (243). We 
observed a robust upregulation of gene expression in proliferative genes, i.e. 
PCNA, E2F1, and MCM2, from the addition of growth factors to NSPCs. 
Accordingly, upon growth factor treatment we detected a large decrease in 
expression of genes involved in differentiation, i.e. DCX and GFAP. However, 
we did not observe any difference in gene expression from treatment with 
exercise-conditioned or transgenic sera compared to sedentary and wildtype. 
We were unable to detect any difference in serum-induced response on 
proliferation from exercise. The increase in proliferation with higher serum 
concentrations is a well-known phenomenon for cell cultures and indicates that 
the assay is capable of detecting serum differences.  
As discussed in Methodology, there are important differences between plasma and 
serum. We cannot exclude the possibility that the use of plasma would have 
yielded different results on neural stem cell behavior. 
We were unable to detect differences in stem cell differentiation between serum 
from exercising versus sedentary animals. Serum treatment shifts differentiation 
to a glial lineage, an effect that is stronger with higher concentrations (244) and 
may largely be mediated by glucocorticoids (245). However, the low molecular 
weight fraction of serum, as opposed to whole-serum, has been proposed to be 
able to promote neural differentiation, while the serum fraction above 100 kDa 
could be toxic for cultured neurons (246). Many neurotrophic factors, such as (e.g. 
EGF, FGF-2, IGF-1, PDGF, cytokines, polyamines, and vitamins), are a part of 
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the molecular weight fraction of serum below 100kDa, this sub-100kDa serum 
fraction in conjunction with FGF-2 promote neuronal differentiation in rodent 
NSPCs (247). However, the interpretation of this finding is difficult since FGF-2 
has been demonstrated to promote neuronal differentiation on its own (248). Peng 
and colleagues evaluated different molecular weight fractions of mouse serum 
from MCK-PGC-1α mice on kidney tubule cells (122). They found that only the 
10-50 kDa fraction could improve mitochondrial function in kidney cells by
significantly increasing ATP-coupled respiration and maximal respiratory
capacity. Using mass spectrometry, the serum fraction was found to contain irisin
with the effects of the serum fraction being blocked by an antibody against irisin,
indicating that irisin mediated these effects. Therefore, the possibility remains that
the response to a low molecular weight fraction of serum could have yielded
different result in our assays.
Inflammatory mediators are known to inhibit neurogenesis, and overexpression of 
PGC-1α downregulates inflammatory activity through NFkB inhibition (249), a 
transcription factor that is also involved in neuronal differentiation. Despite potent 
systemic changes in MCK-PGC-1α animals that we and others have observed 
(122, 138, 153, 159, 164, 170, 171, 176) we did not detect any difference in neural 
stem cell response when treating with serum from MCK-PGC-1α and wildtype 
animals, independent of exercise activity or serum concentration. 
We collected sera from 7- to 10-month-old wildtype and transgenic mice. Factors 
inhibiting neurogenesis could exist in the blood of older mice that could inhibit 
the exercise-induced effects on neural stem cell behavior. It is known that aging 
factors increase in the blood of older mice, such as CCL11 and β2-microglobulin, 
which have been found to impair neurogenesis and cognitive function (202), 
whereas anti-aging factors, which have protective effects, have been found to 
decrease (201). See paper IV for a discussion on the use of older serum that 
contain glucocorticoids and eotaxin/CCL11, among other factors being able to 
negatively impact neurogenesis. It is possible that using blood from younger 
animals could have yielded a different effect of exercised serum on neural stem 
cell behavior.  
We collected serum after 4 weeks of voluntary wheel running in the inactive phase 
of the animals. Due to the difference in regulation of exercise factors after an acute 
exercise bout and regular exercise it is also possible that acute exercise could have 
yielded different effects on neural stem cell behavior. 
Precursor cells from different brain regions do not behave identically under 
identical culture conditions (250). We use NSPCs derived from subcortical tissue 
of early postnatal mice. The two main neurogenic regions in the subcortical 
regions are the SGZ and SVZ. Due to the inherent higher capacity of NSPCs 
derived from SVZ to proliferate in cell culture, in comparison SGZ, it is likely 
that most NSPCs that we have cultured have originated from the SVZ. Since 
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exercise may be limited to induce neurogenesis primarily in the SGZ, and not in 
the SVZ (67), this could mean that the NSPCs from the two neurogenic regions 
intrinsically have different propensities to respond to exercise-induced changes. 
We use subcortical brain tissue which may give away spatial information and 
potential insight into regional differences of NSPCs. Therefore, it is possible that 
using NSPCs derived from subcortical tissue, rather than hippocampal NSPCs, 
could have influenced neural stem cells response for the different mouse sera (see 
Methodology section for commentary).  
Effect of conditioned medium from PGC-1α-transfected 
myocytes on neural stem cells responses 
In paper IV, we sought to determine the effect of conditioned medium from PGC-
1α-transfected myocytes on the response of neural stem cells. Medium was 
harvested from myocytes transfected with plasmid vectors containing either a 
PGC1 or GFP construct under the CMV promoter. Media were conditioned by 
incubation with transfected myocytes for 48 hours before being harvested. At this 
point the myocytes had turned into immature myotubes, while ten days after 
transfection myotubes developed into mature myotubes. In PGC-1α-transfected 
myocytes, Pgc1a mRNA levels were elevated 250-fold with a 3-fold increase in 
VEGF protein levels compared to GFP-transfected myocytes 24 hours after 
transfection, see Figure 16. However, no elevation of VEGF protein levels could 
be detected in the PGC-1α-conditioned media, possibly due to the short half-life 
of VEGF (135). 
PGC-1α upregulation induces expression of VEGF, which regulates angiogenesis 
and vasodilatation in skeletal muscle (2). VEGF is considered to be released into 
the circulation from muscle during exercise, but also to be induced in the 
hippocampus following exercise, where it acts to promote angiogenesis, BDNF 
expression, synaptic plasticity, and neurogenesis (105, 107). Interestingly, Rich 
and colleagues show that skeletal muscle VEGF is essential for exercise-induced 
neurogenesis, even though the exact mechanism has not been clearly established 
(137). 
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Figure 16. Transient transfection in myoblast cultures and validation of 
upregulated target and downstream protein. Images showing (A) myoblast 
culture transfected with GFP plasmid DNA and (B) immunocytochemistry against 
GFP (red) with DAPI (blue), (C) myocytes developed into immature myotubes 3 
days after transfection (at the time of media collection), which (D) continue to 
develop into mature myotubes 10 days after transfection. Graphs show (E) relative 
mRNA levels of PGC-1α in myocytes (normalized to reference gene 18s) (paired 
t-test; *, p<0.05; n=5-6), (F) protein levels of VEGF in myocytes (paired t-test;
**, p<0.01; n=3), and protein levels of VEGF in conditioned medium (paired t-
test; n.s.; n=3). Values are shown as mean ± SEM.
In a proliferation assay, we found a concentration-dependent effect from treatment 
with conditioned media and a higher proliferative response in NSPCs from 
incubation with conditioned media coming from PGC1α- compared to GFP-
transfected myocytes, see Figure 17. 
Myocytes used in this study were allowed to differentiate for 3 days at the time of 
medium collection, which is comparable to a previous study in which myocytes 
had differentiated for 2 days (144). It is known that the gene expression and 
proteomic profile of myoblast differ from differentiated myotubes (251). It is 
possible that upregulation of PGC-1α in fully differentiated myotubes could have 
yielded other results. Primary myoblasts were used to allow for adequate 
transfection efficiency with transient lipotransfection of plasmid DNA. However, 
it may have been preferable to transduce primary myoblast with a retroviral vector 
containing a mammalian antibiotic resistance gene (e.g., puromycin, basticidin), 
which would have enabled selection of a stable cell culture after transduction. A 
homogenous cell culture prepared by selection of transduced cells would have 
increased reproducibility by eliminating the variation associated with repeated 
transient transfections. This would have allowed the continued culturing and 
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selection of myoblasts retrovirally transduced with an inducible gene expression, 
such as Tet-on (252), and enabled us to turn on the PGC-1α expression in fully 
differentiated myotubes. 
Since the conditioned medium contains metabolites from the myocyte culture it is 
also possible that we would have observed different results by purifying proteins 
in the conditioned media through protein precipitation (2) or through dialysis. 
Several potential myokines regulated by the PGC-1α pathway could mediate the 
observed proliferative effect. For example, FNDC5, or irisin, is upregulated by 
PGC-1α overexpression and is increased in the circulation following exercise 
training (130). Irisin increases proliferation of NSPCs at pharmacological doses 
in vitro (126), and FNDC5 is reported to upregulate hippocampal BDNF levels 
(3), which could increase proliferation of NSPCs by different signaling pathways 
(253). 
Figure 17. Proliferative response of NSPCs upon treatment with conditioned 
media from PGC-1α-overexpressing myocytes. Graphs show proliferation 
analysis of NSPCs treated with a range of concentrations of conditioned media 
from (A) GFP-transfected myocytes (RM-ANOVA, Tukey multiple comparisons; 
n.s.; n=3) and (B) comparison of conditioned media from PGC-1α- and GFP-
overexpressing myocytes (RM-ANOVA; treatment group effect, F(1,4)=8.0,
p=0.05; concentration effect, F(4,16)=3.6, p=0.03; n=5 biological replicates),
showing a higher proliferative response with the PGC-1α-transfected conditioned
media. Dashed line indicates that ‘–GF’ and ‘+GF’ have not been included in the
statistical analysis. Values are shown as mean ± SEM. *, p<0.05. GF, growth
factors; ‘-GF’, culture medium without GF; ‘+GF’, culture medium with GF.
CONCLUDING REMARKS  60 
CONCLUDING REMARKS 
In this chapter we summarize and discuss the conclusions made in each paper in 
relation to the aims of this thesis. 
In paper I, we found that muscular overexpression of PGC-1α does not exert 
beneficial effects on adult neurogenesis after cranial irradiation, or on the 
morphological outcome after cortical stroke, indicating that PGC-1α 
overexpression in muscle is not sufficient to phenocopy exercise-induced 
neuroprotection in these injury models.  
In paper II, we found that muscular overexpression of PGC-1α does not exert 
beneficial effects on adult neurogenesis, independent of sex or age, indicating that 
PGC-1α overexpression in muscle is not sufficient to phenocopy exercise-induced 
neurogenesis in aging. 
In paper III, we found that muscular overexpression of PGC-1α does not increase 
basal neurogenesis, or augment exercise-induced neurogenesis, independent of 
age, indicating that PGC-1α overexpression in muscle is not sufficient to 
phenocopy exercise-induced effects on neurogenesis.  
In paper IV, we found that serum from animals subjected to voluntary running 
and animals with muscular overexpression of PGC-1α did not affect proliferation 
or differentiation of neural stem cells. This suggests that circulating factors 
induced by exercise, or muscle-specific PGC-1α overexpression, are not sufficient 
to directly influence neural stem cell behavior. 
Based on previously reported upregulation of systemic factors with neurotrophic 
effects in MCK-PGC-1α mice (2), we hypothesized that constitutive muscular 
PGC-1α overexpression could result in increased basal neurogenesis, and that 
exercise could act in synergy with this effect. Further, MCK-PGC-1α animals 
were reportedly protected from stress-induced neuroinflammation (138), and we 
hypothesized that a similar protective effect could emerge in other 
neuroinflammatory conditions that have been shown to be benefited by exercise, 
such as cranial irradiation, cortical stroke, and age-dependent decline of 
neurogenesis. However, we found no protection by muscle-specific 
overexpression of PGC-1α in models of brain injury and no difference between 
genotypes regarding basal neurogenesis, independent of age or sex. Furthermore, 
we did not see any further improvement in exercise-induced neurogenesis in 
MCK-PGC-1α animals. The lack of synergistic effect is in line with a finding that 
endurance training increased PGC-1α mRNA levels in gastrocnemius by two-fold 
in WT, while no further increase could be seen in MCK-PGC-1α animals (171). 
Moreover, muscle-specific PGC-1α overexpression did not augment metabolic 
effects from exercise (254). 
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We also hypothesized that effects from exercise or muscle-specific PGC-1α 
overexpression may be present upon treatment of neural stem cells in vitro. 
However, we found no effect of exercise or muscle-specific PGC-1α 
overexpression from whole-serum treatment on neural stem cell proliferation or 
differentiation. Metabolic effects of acute exercise bouts are very different from 
metabolic adaptations to regular exercise training, with only a few myokines being 
upregulated in both acute and regular exercise (255). Chronic expression of PGC-
1α could be regarded as an adaptive response to long-term regular physical 
exercise and may not have the same effects on hippocampal neurogenesis as an 
acutely elevated expression of the transcription factor. For this reason, we also 
sought to investigate the acute effects of upregulating the PGC-1α pathway by 
acute overexpression in myocytes. We hypothesized that an acute overexpression 
of PGC-1α in myocytes may secrete factors into the condition media, which may 
influence neural stem cell behavior. We observed a slight increase in neural stem 
cell proliferation from conditioned media coming from PGC-1α-transfected 
myocytes.  
In order to finalize our studies and further validate our findings, we are in the 
process of producing immunoblots for PGC-1α protein expression in 
gastrocnemius muscle homogenate of wildtype and MCK-PGC-1α animals, as 
well as for PGC-1α-transfected myocytes. 
In several experiments we have demonstrated the lack of beneficial effects from 
chronic muscle-specific overexpression of PGC-1α on neurogenesis and 
protection from brain insults. We find that chronic muscle activation through the 
PGC-1α pathway is not sufficient to mimic exercise-induced effects on 
neurogenesis or protection from brain insults, and that serum factors secreted by 
exercise or chronic muscle activation through the PGC-1α pathway is in 
physiological levels not able to directly influence neural stem cell behavior in 
vitro. We have studied neurogenesis for the importance of this phenomenon in 
exercise-induced effects on the CNS and in cognition. However, exercise-induced 
effects on cognition are also correlated to enhanced neuronal and synaptic 
plasticity (256). While neurogenesis is important for exercise-induced 
improvements in spatial memory, it is not required for improvements in motor 
performance or contextual fear conditioning (102, 257). It should therefore be 
noted that we have not studied electrophysiological or behavioral aspect of 
exercise-induced effects on the brain.  
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Models of muscular PGC-1α overexpression 
In cell culture studies, adenovirus-mediated PGC-1α overexpression in C2C12, 
L6 (258), and primary rat myotubes (259), resulted in increased GLUT4 
expression and glycogen build-up, suggesting a PGC-1α-mediated enhancement 
of glucose homeostasis in skeletal muscle. This was supported by the finding that 
enhanced insulin-stimulated glycogen synthesis by antidiabetic agents in primary 
human muscle cells was mediated by GLUT4 upregulation via PGC-1α induction 
(260). Similarly, electroporation of PGC-1α that resulted in ~25% increase in 
PGC-1α protein expression in tibialis anterior skeletal muscle yielded an increased 
GLUT4 expression and glucose uptake ex vivo (261). 
However, in a transgenic mouse model of muscle-specific overexpression of 
PGC-1α (10-fold increase in gene expression) that displayed red colored muscle 
phenotype characteristic of oxidative muscle, Miura and colleagues unexpectedly 
observed a downregulation of GLUT4 mRNA (262). Choi and colleagues used 
MCK-PGC-1α animals with a 6-fold increase in PGC-1α gene expression in 
muscle composed of type II fibers (175), which is within the range of the increase 
observed after exercise training (10-13-fold increase according to Miura and 
colleagues), and similar to that found in type I muscle fibers (262). MCK-PCG-
1α mice had increased mitochondrial function, but displayed aggravated fat-
induced muscle insulin resistance (175). In MCK-PGC-1α muscle there was a 
140% increase in mitochondrial density, but only a 60% increase in ATP 
synthesis, suggesting a partial downregulation of activity per unit of mitochondrial 
mass. The results from in vitro and ex vivo studies may also indicate that an acute 
overexpression could be responsible for the beneficial effect on glucose 
homeostasis. 
Wende and colleagues used a transgenic mouse model of inducible PGC-1α 
overexpression in skeletal muscle and found that overexpression of PGC-1α 
reduced high-intensity exercise capacity after 3-4 weeks following induction, 
explained by a decreased ability to utilize glycogen during exercise. Muscle-
specific activation of PGC-1α increased muscle glucose uptake, suppressed 
glycolysis and glycogen breakdown, normally stimulated by insulin, leading to an 
increase in glycogen fuel depot similar to endurance training. In addition to the 
temporal differences in PGC-1α expression, the model used by Wende and the 
MCK-PCG-1α model likely exhibit differences in expression levels (153, 160). 
The many faces of PGC-1α add to the complexity of the regulation and functions 
of this gene. Baar and colleagues found that PGC-1α has at least two protein 
isoforms, one full-length form and one smaller 34-kDa form (263). Later, it was 
demonstrated that transcription of the canonical exon (exon 1a) was increased by 
high intensity exercise and AICAR, which gave rise to the PGC-1α-a (PGC-1α1) 
isoform, while the alternative exon 1b drove expression from low-, medium- and 
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high-intensity exercise, AICAR, and clenbuterol (β2-receptor agonist), gave with 
alternative splicing rise to PGC-1α-b (PGC-1α4) and PGC-1α-c (264). Various 
isoforms appears to have different functions (265). Truncated forms of PGC-1α 
have been reported to be more stable and primarily regulate angiogenesis, while 
full-length forms primarily regulate mitochondrial biogenesis. It should be noted 
that there are differences in how muscle-specific PGC-1α overexpressing 
transgenic mouse models have been produced, which makes it difficult to make 
direct comparisons between models (153, 261, 262). Two independent PGC-1α1 
transgenic mouse models have been observed to exhibit different phenotypes. For 
example, MCK-PGC-1α animals are reported to prevent denervation and fasting-
induced skeletal muscle atrophy (164), while another model displayed increased 
muscular atrophy (266) and dilated cardiomyopathy (267). 
Metabolic effects in MCK-PGC-1α mice are activity-dependent 
MCK-PGC-1α mice have increased vO2max, but no change in whole-body 
glucose homeostasis or insulin sensitivity under either fed and fasting sedentary 
conditions (159). Thus, the PGC-1α transgenic mice do not exhibit differences in 
multiple metabolic parameters under basal conditions, but display lower 
respiratory exchange ratio during exercise, indicating an enhanced fat metabolism 
and fuel utilization. PGC-1α promotes anabolic processes, including synthesis and 
storage of intramyocellular glycogen (160) and lipids (268). Increased 
intramyocellular lipid droplets is a signature of increased fuel storage related to 
exercise training, with the term “athlete’s paradox” implying that high oxidative 
capacity and increased insulin sensitivity from endurance exercise occurs in 
parallel with accumulation of glycogen and intramyocellular lipid. Lipid 
accumulation is not an issue under physiological conditions due to constant 
substrate turnover in exercise (269). Under normal physiological conditions of 
exercise, PGC-1α induces a coordinated program of increased energy delivery, 
mitochondrial biogenesis, and fatty acid oxidation to meet the increased energy 
demands of working skeletal muscle (175). Despite the strong promotion of an 
exercised muscle phenotype, elevated expression of PGC-1α in sedentary mice 
exacerbates diet-induced insulin resistance (175), due to intramyocellular lipid 
accumulation from increased fatty acid uptake and re-esterification exceeding 
mitochondrial fat oxidation. However, elevated expression of PGC-1α in 
exercising mice enhances exercise-induced improvements in glucose 
homeostasis, oxidative capacity and lipid partitioning (176, 268). 
MCK-PGC-1α mice may have too high PGC-1α levels 
According to a review, the physiological induction of PGC-1α from acute and 
exercise training should be between ~50-300% increase in mRNA and protein 
levels (270). Supraphysiological PGC-1α production >600% induces many 
undesirable consequences, including abnormal mitochondrial proliferation, 
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disruption of myofibrillar architecture, intramuscular lipid accumulation, and 
insulin resistance (175, 262). The fatty acid transporter FAT/CD36 is a PGC-1α-
inducible gene that has been linked to insulin resistance due to its function to 
increase uptake of fatty acids outside the cells capability for oxidization, resulting 
in lipid accumulation (270). A modest increase in PGC-1α expression by ~25%, 
limited FAT upregulation and lipid accumulation, as well as improved fatty acid 
oxidation, insulin signaling and glucose transport (161, 261). The benefit of 
physiological overexpression is supported by a study using whole-body 
overexpressing PGC-1α transgenic mice, at a ~2-fold increased gene expression, 
which displayed improved muscle insulin resistance, an effect which was 
neutralized by high-fat diet (271). Therefore, it is possible that the PGC-1α dose 
has to be carefully titrated to avoid unwanted effects. A transgenic mouse model 
with modest overexpression of PGC-1α may have displayed different effects on 
the CNS than what we have observed in the MCK-PGC-1α. However, it is not 
known if a modest upregulation of PGC-1α would have yielded the same response 
in secretable myokines (2, 122). 
Mimicking exercise-induced effects on the CNS 
Evidence for effect of exercise factors on the brain 
Exercise improves general brain health, brain plasticity and cognition, and 
evidence indicates that factors secreted by peripheral organs are involved in this 
regulation. For example, the PGC-1α-inducible myokine FNDC5 can induce acute 
effects in the brain when adenovirus with a FNDC5 construct is injected in the 
liver (3) or intravenously (123). Further, the pro-angiogenic PGC-1α-inducible 
factor VEGF in muscle has been found to be necessary for exercise-induced 
neurogenesis (2, 137). Likewise, skeletal muscle activation by AICAR and GW 
can induce short-term effects on neurogenesis, neuroprotection, and cognition (4, 
182, 272, 273). The AMPK- and PGC-1α-inducible myokine cathepsin B can pass 
through the BBB to enhance hippocampal BDNF levels, neurogenesis, learning 
and memory (109). Apart from these factors, also other factors secreted by muscle, 
adipose tissue (e.g. adiponectin), and liver (e.g. FGF-21, IGF-1), mediate 
exercise-induced effects on neurogenesis, cognitive function, appetite and 
metabolism. Exercise-induced conversion of the neuroinflammatory tryptophane 
metabolite kynurenin to kynurenic acid is enhanced in MCK-PGC-1α animals 
(138), indicating the importance of peripheral metabolism in exercise-induced 
effects on the brain. Finally, MCK-PGC-1α have upregulated levels of circulating 
myokines with neurotrophic properties such as irisin, BNDF, and IL-15, capable 
of having potent effects on the CNS (122). 
 65  CONCLUDING REMARKS 
The difficulty in mimicking exercise-induced effects on the CNS 
Evidence from the above-mentioned studies suggest that muscle-derived exercise-
induced signaling influences neuroplasticity under physiological and 
pathophysiological conditions. From our studies, we found that muscle-specific 
PGC-1α overexpression did not improve recovery or protection from neurological 
conditions such as irradiation-injury to the brain, ischemic stroke, or age-related 
cognitive decline. Further, we found no differences between genotypes in basal or 
exercise-induced levels of neurogenesis, independent of age or sex. Our results 
based on whole-serum and protein analysis of serum, suggest that factors induced 
in the circulation by exercise, or by overexpression of PGC-1α in skeletal muscle 
cells, are not able to directly affect neural stem cell behavior. In summary, we 
conclude that forced expression of the PGC-1α pathway in skeletal muscle is not 
sufficient to mimic exercise-induced neurogenesis. 
An acute peripheral overexpression of FNDC5 has been reported to increase 
BDNF expression in the hippocampus (3). Intravenous injection of an adenoviral 
vector, which upregulated the circulating level of FNDC5 improved synaptic 
plasticity and memory impairment in a mouse model of Alzheimer’s disease 
(123). We find that upregulation of the PGC-1α/FNDC5 pathway in muscle is not 
sufficient to achieve exercise-induced effects on the CNS and that upregulation in 
other tissues may be necessary (3, 123). The question also remains if the long-
term effects of exercise on the brain could be achieved sustainably by 
pharmacological or genetic therapy alone. Pharmacological activation of the 
AMPK pathway in skeletal muscle, which also reliable upregulates the PGC-1α 
pathway, indeed leads to a short-term increase in hippocampal BDNF expression 
and proliferation in the DG. However, after a few weeks of treatment these effects 
were lost and replaced with overexpression of pro-apoptotic and inflammatory 
genes in muscle (182). The study mentioned above, by Lourenco, and a study by 
Choi that reported improved cognition in an Alzheimer’s mouse model by 
combined treatment with intravenous injections with AICAR and intracerebral 
injection with BDNF (272), both reported effects of treatment up to a 2-week time 
point. Our results from chronic upregulation of PGC-1α in muscle is relevant in 
predicting sustainable effects from activation of exercise-induced pathways in 
muscle, particularly considering the sustained upregulation of potent systemic 
factors in the circulation reported for the MCK-PGC-1α model (122). In contrast 
to these acute models of FNDC5 pathway stimulation, our chronic muscle 
activation model factors in complex compensatory counter-regulation that may 
occur over time. 
Exercise induces adaptations in every organ of the body (274) with profound 
benefits for neural, immunological, vascular, and metabolic systems. Exercise is 
a complex stimulus affecting a range of tissues and cellular processes, that up- and 
downregulate thousands of genes with both temporally and spatially distinct 
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patterns. The mechanisms by which different modes of exercise may affect brain 
function remain to be elucidated. Further, caution should also be used when 
extrapolating factors to potential therapeutic treatment with seemingly healthy 
factors secreted by muscle cells may also have detrimental effects in other 
conditions (118). For instance, the proliferative mediator IGF-1 can also promote 
cancer (275) and decrease life span (276). 
Controversies in the field of exercise-mimetics 
Since the start of this PhD project in early 2012, several publications have 
emerged to fill the knowledge gaps in the field, which in some ways have changed 
our original assumptions and hypotheses. There is a need to continuously assess 
the merit of reported findings in the scientific community. Two papers reporting 
on positive metabolic, protection from muscle wasting and improvement of 
mitochondrial myopathy disorder in MCK-PGC-1α mice, were later retracted in 
2016 (277, 278). In one of the retracted papers, MCK-PGC-1α mice was reported 
to have improved metabolic responses as evident by increased insulin sensitivity 
and insulin signaling, as well as being protected against systemic chronic 
inflammation observed during normal aging (278). 
Irisin, meteorin-like, and BAIBA, are all exercise-inducible myokines regulated 
by PGC-1α, which have been reported by the Spiegelman lab. The best described 
factor of these is irisin, which was first reported in 2012. Irisin is produced by 
cleavage of the transmembrane protein FNDC5 for release into the circulation, 
triggering the appearance of inducible brown adipose tissue within white fat, as 
well as being increased in the circulation from exercise in humans (2, 130). This 
paper immediately received a lot of attention, even in the lay press and spurred a 
number of follow-up studies. However, observed levels of circulating irisin were 
highly variable and contradictory (279). Timmons found that muscle FNDC5 
mRNA expression was increased only in a minority of older endurance-trained 
human subjects and that exercise-induced improvements in insulin sensitivity 
were not associated with FNDC5 gene expression (280). In another study, PGC-
1α mRNA levels were only upregulated 4-fold in young and 2-fold in older men 
after an acute exercise bout, but not after endurance training (281). Due to the fact 
that commercially available ELISA kits used in publications to measure irisin 
were unspecific and detected cross-reacting proteins, Albrecht and colleagues 
concluded that irisin was not proven to be an exercise-inducible protein (129). 
However, the Spiegelman lab used tandem mass spectrometry to report that irisin 
was increased from 3.5 ng/ml in sedentary humans to 4.3 ng/ml in individuals that 
underwent 8 weeks of high intensity aerobic training, which can be considered a 
relatively small increase and the observation was based on 10 individuals (130). 
Due to these marginal differences in humans, and the previously used unspecific 
ELISAs, the extent circulating irisin is increased in humans needs to be validated 
in future studies. 
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Exercise leads to many physiological changes in the body and brain, including 
improved cardiovascular fitness, reduced inflammatory status, reduced oxidative 
stress, increased cerebral blood flow with improved exchange of oxygen, 
nutrients, metabolites in the brain, all which likely have a substantial role to play 
in exercise-induced effects on the CNS. Exercise exerts these effects on the body 
and brain by activating a complex network of pathways in different cell types, 
tissues, and organs, in a periodic and dynamic manner (274). Through the use of 
transcriptomics, proteomics, and metabolomics, attempts have been made to map 
out exercise pathways in muscle and exercise-induced factors in the blood. Even 
though a multitude of exercise factors have been identified, it is still unclear if and 
how much these factors contribute to exercise-induced effects. This would require 
comprehensive evaluation for each of these factors, in loss-of-function, gain-of-
function and pharmacological targeting studies. It is a non-trivial endeavor due to 
the fact that patterns of factor expression differ between individuals, studies, 
species, modes of exercise, etc. The study of exercise-activated pathways by 
genetical and pharmacological approaches allows evaluation of the combined 
effect of downstream factors of certain signaling pathways that enable easier 
identification of factors. Through these studies, a few candidates released into the 
circulation from exercise have been identified as capable of inducing exercise-
induced effects on the brain.  
Even though genetic and pharmacological approaches of muscle activation have 
reported potent effects on the CNS, none have yet to report sustainable effects, 
possibly due to compensatory adaptations occurring in longer-term treatment. 
Exercise-induced neurogenesis is one of the most reproducible findings of 
exercise-induced changes on the rodent brain and has a central role in exercise-
induced brain plasticity and cognition. We demonstrate that a sustained 
upregulation of the muscular PGC-1α pathway, despite potent systemic changes, 
is not sufficient to phenocopy exercise-induced neurogenesis. From this, we 
conclude that upregulation of the PGC-1α pathway in skeletal muscle is not 
sufficient to directly induce sustainable exercise-induced effects in the brain. 
The study of PGC-1α, together with its related molecular pathways and 
downstream targets, contributes to our understanding of exercise-related benefits 
on the brain. The essential role of PGC-1α in mitochondrial metabolism and 
regulation of inflammation has made it a possible therapeutic target for a wide 
range of diseases. The findings presented here offer new insights for continued 
studies of PGC-1α, and provide evidence that upregulation of this co-activator 
under certain pathological conditions can even have detrimental effects. 
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Our findings raise doubts that pharmacological targeting of exercise-induced 
systemic factors can achieve sustainable effects on the CNS. However, 
pharmacological strategies based on exercise-induced effects remain an intriguing 
concept, even though a limited range of exercise-induced effects need to be aimed 
for. As previously discussed regarding the metabolic effects of artificial skeletal 
muscle activation, the necessity to actually consume energy will be an important 
limitation in exercise-mimicking manipulations. Perhaps such pharmacological 
possibilities could involve exercise adjuvants for enhancing health-promoting 
effects (282). It is also likely that more than one pathway will have to be targeted 
in order to achieve an exercise-mimicking effect (283).  
Future perspective 
Further studies are needed to determine if a modest overexpression of PGC-1α 
and downstream factors in skeletal muscle could confer sustainable exercise-
induced effects in the CNS. Furthermore, continued studies are required to 
determine what other pathways in muscle and other tissues, as well as which 
circulating signals that could be important for mediating exercise-inducing 
changes on the brain. Especially, the findings in thesis highlights the necessity of 
understanding temporal aspects of crosstalk between brain and other tissues 
during exercise. A thorough understanding of the complex molecular mechanisms 
underlying exercise-induced effects on the body and brain could enable the 
discovery of new pharmacological targets, the identification of biomarkers for 
measuring health status, and the optimization of physical therapy based on 
genetics and molecular responses. Novel treatment strategies could aid in the 
management of neurological and neurocognitive impairments, as well as to 
increase quality of life in cancer and stroke survivors.
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